US20170204370A1 - Methods for staining cells for identification and sorting - Google Patents
Methods for staining cells for identification and sorting Download PDFInfo
- Publication number
- US20170204370A1 US20170204370A1 US15/476,509 US201715476509A US2017204370A1 US 20170204370 A1 US20170204370 A1 US 20170204370A1 US 201715476509 A US201715476509 A US 201715476509A US 2017204370 A1 US2017204370 A1 US 2017204370A1
- Authority
- US
- United States
- Prior art keywords
- syto
- sperm
- green
- dye
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 66
- 238000010186 staining Methods 0.000 title claims abstract description 24
- 241000283690 Bos taurus Species 0.000 claims abstract description 15
- 239000000975 dye Substances 0.000 claims description 79
- 102000039446 nucleic acids Human genes 0.000 claims description 42
- 108020004707 nucleic acids Proteins 0.000 claims description 42
- 150000007523 nucleic acids Chemical class 0.000 claims description 40
- 239000002105 nanoparticle Substances 0.000 claims description 28
- 239000002096 quantum dot Substances 0.000 claims description 24
- 102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 20
- 108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 20
- -1 LOLO-1 Chemical compound 0.000 claims description 16
- 239000012528 membrane Substances 0.000 claims description 16
- 210000000349 chromosome Anatomy 0.000 claims description 14
- 230000035899 viability Effects 0.000 claims description 11
- 241001465754 Metazoa Species 0.000 claims description 10
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 7
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 claims description 7
- 239000007850 fluorescent dye Substances 0.000 claims description 6
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 claims description 5
- 230000008685 targeting Effects 0.000 claims description 5
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical class [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 claims description 4
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 4
- QHNORJFCVHUPNH-UHFFFAOYSA-L To-Pro-3 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 QHNORJFCVHUPNH-UHFFFAOYSA-L 0.000 claims description 4
- ZVUUXEGAYWQURQ-UHFFFAOYSA-L Yo-Pro-3 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 ZVUUXEGAYWQURQ-UHFFFAOYSA-L 0.000 claims description 4
- GRRMZXFOOGQMFA-UHFFFAOYSA-J YoYo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2O1 GRRMZXFOOGQMFA-UHFFFAOYSA-J 0.000 claims description 4
- JSBNEYNPYQFYNM-UHFFFAOYSA-J YoYo-3 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=CC=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC(=[N+](C)C)CCCC(=[N+](C)C)CC[N+](C1=CC=CC=C11)=CC=C1C=CC=C1N(C)C2=CC=CC=C2O1 JSBNEYNPYQFYNM-UHFFFAOYSA-J 0.000 claims description 4
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 claims description 4
- 229960005542 ethidium bromide Drugs 0.000 claims description 4
- NMKIHZILXGGHHL-UHFFFAOYSA-N n,n'-bis[3-[(6-chloro-2-methoxyacridin-9-yl)amino]propyl]butane-1,4-diamine Chemical compound C1=C(OC)C=C2C(NCCCNCCCCNCCCNC3=C4C=CC(Cl)=CC4=NC4=CC=C(C=C43)OC)=C(C=CC(Cl)=C3)C3=NC2=C1 NMKIHZILXGGHHL-UHFFFAOYSA-N 0.000 claims description 4
- 241000894007 species Species 0.000 claims description 4
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 claims description 3
- NZVGXJAQIQJIOY-UHFFFAOYSA-N 4-[6-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-benzimidazol-2-yl]benzenesulfonamide;trihydrochloride Chemical compound Cl.Cl.Cl.C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(=CC=3)S(N)(=O)=O)C2=C1 NZVGXJAQIQJIOY-UHFFFAOYSA-N 0.000 claims description 3
- BGWLYQZDNFIFRX-UHFFFAOYSA-N 5-[3-[2-[3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propylamino]ethylamino]propyl]-6-phenylphenanthridin-5-ium-3,8-diamine;dichloride Chemical compound [Cl-].[Cl-].C=1C(N)=CC=C(C2=CC=C(N)C=C2[N+]=2CCCNCCNCCC[N+]=3C4=CC(N)=CC=C4C4=CC=C(N)C=C4C=3C=3C=CC=CC=3)C=1C=2C1=CC=CC=C1 BGWLYQZDNFIFRX-UHFFFAOYSA-N 0.000 claims description 3
- XYJODUBPWNZLML-UHFFFAOYSA-N 5-ethyl-6-phenyl-6h-phenanthridine-3,8-diamine Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2N(CC)C1C1=CC=CC=C1 XYJODUBPWNZLML-UHFFFAOYSA-N 0.000 claims description 3
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 claims description 3
- 108700012813 7-aminoactinomycin D Proteins 0.000 claims description 3
- TYBKADJAOBUHAD-UHFFFAOYSA-J BoBo-1 Chemical compound [I-].[I-].[I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC3=[N+](C4=CC=CC=C4S3)C)C=C2)C=C1 TYBKADJAOBUHAD-UHFFFAOYSA-J 0.000 claims description 3
- UIZZRDIAIPYKJZ-UHFFFAOYSA-J BoBo-3 Chemical compound [I-].[I-].[I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC=CC3=[N+](C4=CC=CC=C4S3)C)C=C2)C=C1 UIZZRDIAIPYKJZ-UHFFFAOYSA-J 0.000 claims description 3
- 241000283073 Equus caballus Species 0.000 claims description 3
- 241000282326 Felis catus Species 0.000 claims description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
- 241000009328 Perro Species 0.000 claims description 3
- QBKMWMZYHZILHF-UHFFFAOYSA-L Po-Pro-1 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)C)C=C1 QBKMWMZYHZILHF-UHFFFAOYSA-L 0.000 claims description 3
- CZQJZBNARVNSLQ-UHFFFAOYSA-L Po-Pro-3 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C1C=CN(CCC[N+](C)(C)C)C=C1 CZQJZBNARVNSLQ-UHFFFAOYSA-L 0.000 claims description 3
- BOLJGYHEBJNGBV-UHFFFAOYSA-J PoPo-1 Chemical compound [I-].[I-].[I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC3=[N+](C4=CC=CC=C4O3)C)C=C2)C=C1 BOLJGYHEBJNGBV-UHFFFAOYSA-J 0.000 claims description 3
- GYPIAQJSRPTNTI-UHFFFAOYSA-J PoPo-3 Chemical compound [I-].[I-].[I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC=CC3=[N+](C4=CC=CC=C4O3)C)C=C2)C=C1 GYPIAQJSRPTNTI-UHFFFAOYSA-J 0.000 claims description 3
- 241000700159 Rattus Species 0.000 claims description 3
- 241000282898 Sus scrofa Species 0.000 claims description 3
- DPXHITFUCHFTKR-UHFFFAOYSA-L To-Pro-1 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 DPXHITFUCHFTKR-UHFFFAOYSA-L 0.000 claims description 3
- MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 claims description 3
- 210000002593 Y chromosome Anatomy 0.000 claims description 3
- ULHRKLSNHXXJLO-UHFFFAOYSA-L Yo-Pro-1 Chemical compound [I-].[I-].C1=CC=C2C(C=C3N(C4=CC=CC=C4O3)C)=CC=[N+](CCC[N+](C)(C)C)C2=C1 ULHRKLSNHXXJLO-UHFFFAOYSA-L 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 238000000338 in vitro Methods 0.000 claims description 3
- 239000000178 monomer Substances 0.000 claims description 3
- XJCQPMRCZSJDPA-UHFFFAOYSA-L trimethyl-[3-[4-[(e)-(3-methyl-1,3-benzothiazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]azanium;diiodide Chemical compound [I-].[I-].S1C2=CC=CC=C2N(C)\C1=C\C1=CC=[N+](CCC[N+](C)(C)C)C=C1 XJCQPMRCZSJDPA-UHFFFAOYSA-L 0.000 claims description 3
- FGBAVQUHSKYMTC-UHFFFAOYSA-M LDS 751 dye Chemical compound [O-]Cl(=O)(=O)=O.C1=CC2=CC(N(C)C)=CC=C2[N+](CC)=C1C=CC=CC1=CC=C(N(C)C)C=C1 FGBAVQUHSKYMTC-UHFFFAOYSA-M 0.000 claims description 2
- 241000282341 Mustela putorius furo Species 0.000 claims description 2
- 241001416177 Vicugna pacos Species 0.000 claims description 2
- VMCOQLKKSNQANE-UHFFFAOYSA-N n,n-dimethyl-4-[6-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-benzimidazol-2-yl]aniline Chemical compound C1=CC(N(C)C)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 VMCOQLKKSNQANE-UHFFFAOYSA-N 0.000 claims description 2
- 230000004720 fertilization Effects 0.000 claims 2
- 238000012217 deletion Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 210000001161 mammalian embryo Anatomy 0.000 claims 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 claims 1
- 238000004520 electroporation Methods 0.000 abstract description 34
- 238000011282 treatment Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 159
- 108020004414 DNA Proteins 0.000 description 41
- 102000053602 DNA Human genes 0.000 description 41
- 239000000243 solution Substances 0.000 description 23
- 239000000523 sample Substances 0.000 description 21
- 210000000170 cell membrane Anatomy 0.000 description 16
- 230000005684 electric field Effects 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 239000003990 capacitor Substances 0.000 description 11
- 239000000872 buffer Substances 0.000 description 10
- 230000003204 osmotic effect Effects 0.000 description 10
- 102000040430 polynucleotide Human genes 0.000 description 10
- 108091033319 polynucleotide Proteins 0.000 description 10
- 239000002157 polynucleotide Substances 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 230000027455 binding Effects 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 239000000815 hypotonic solution Substances 0.000 description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 7
- 230000005284 excitation Effects 0.000 description 7
- 239000000819 hypertonic solution Substances 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000001413 cellular effect Effects 0.000 description 6
- 235000013601 eggs Nutrition 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 210000001766 X chromosome Anatomy 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 238000000684 flow cytometry Methods 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 244000309464 bull Species 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 210000004940 nucleus Anatomy 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 3
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 3
- 230000004568 DNA-binding Effects 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000000295 emission spectrum Methods 0.000 description 3
- 229940021223 hypertonic solution Drugs 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000003068 molecular probe Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 210000003765 sex chromosome Anatomy 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000019100 sperm motility Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- AJTVSSFTXWNIRG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid Chemical compound OCC[NH+](CCO)CCS([O-])(=O)=O AJTVSSFTXWNIRG-UHFFFAOYSA-N 0.000 description 2
- BNBQQYFXBLBYJK-UHFFFAOYSA-N 2-pyridin-2-yl-1,3-oxazole Chemical class C1=COC(C=2N=CC=CC=2)=N1 BNBQQYFXBLBYJK-UHFFFAOYSA-N 0.000 description 2
- 241000270728 Alligator Species 0.000 description 2
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 2
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 2
- OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 description 2
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- 102000006947 Histones Human genes 0.000 description 2
- 108010033040 Histones Proteins 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 2
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- SMNPLAKEGAEPJD-UHFFFAOYSA-N chembl34922 Chemical compound Cl.Cl.Cl.C1CN(C)CCN1C1=CC=C(NC(=N2)C=3C=C4N=C(NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 SMNPLAKEGAEPJD-UHFFFAOYSA-N 0.000 description 2
- 230000001010 compromised effect Effects 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000695 excitation spectrum Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 2
- 238000009830 intercalation Methods 0.000 description 2
- 230000002687 intercalation Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000008384 membrane barrier Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 238000006303 photolysis reaction Methods 0.000 description 2
- 230000015843 photosynthesis, light reaction Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000005132 reproductive cell Anatomy 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- WGTODYJZXSJIAG-UHFFFAOYSA-N tetramethylrhodamine chloride Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C(O)=O WGTODYJZXSJIAG-UHFFFAOYSA-N 0.000 description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000007794 visualization technique Methods 0.000 description 2
- DRLIANXPAARUMI-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) pentanoate Chemical class CCCCC(=O)ON1C(=O)CCC1=O DRLIANXPAARUMI-UHFFFAOYSA-N 0.000 description 1
- AASBXERNXVFUEJ-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) propanoate Chemical class CCC(=O)ON1C(=O)CCC1=O AASBXERNXVFUEJ-UHFFFAOYSA-N 0.000 description 1
- HALGLMAADGHVSV-UHFFFAOYSA-N 1-aminopropane-2-sulfonic acid Chemical compound NCC(C)S(O)(=O)=O HALGLMAADGHVSV-UHFFFAOYSA-N 0.000 description 1
- OBYNJKLOYWCXEP-UHFFFAOYSA-N 2-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]-4-isothiocyanatobenzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(N=C=S)=CC=C1C([O-])=O OBYNJKLOYWCXEP-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- RZQXOGQSPBYUKH-UHFFFAOYSA-N 3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound OCC(CO)(CO)NCC(O)CS(O)(=O)=O RZQXOGQSPBYUKH-UHFFFAOYSA-N 0.000 description 1
- IHDBZCJYSHDCKF-UHFFFAOYSA-N 4,6-dichlorotriazine Chemical compound ClC1=CC(Cl)=NN=N1 IHDBZCJYSHDCKF-UHFFFAOYSA-N 0.000 description 1
- IHHSSHCBRVYGJX-UHFFFAOYSA-N 6-chloro-2-methoxyacridin-9-amine Chemical compound C1=C(Cl)C=CC2=C(N)C3=CC(OC)=CC=C3N=C21 IHHSSHCBRVYGJX-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108700016232 Arg(2)-Sar(4)- dermorphin (1-4) Proteins 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N Azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 101710096438 DNA-binding protein Proteins 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- 239000012594 Earle’s Balanced Salt Solution Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 239000007996 HEPPS buffer Substances 0.000 description 1
- 238000010867 Hoechst staining Methods 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 102000006830 Luminescent Proteins Human genes 0.000 description 1
- 108010047357 Luminescent Proteins Proteins 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- NKAVWWIFECJMQA-UHFFFAOYSA-N N=C=S.C1=CC=C2OC=CC2=C1 Chemical class N=C=S.C1=CC=C2OC=CC2=C1 NKAVWWIFECJMQA-UHFFFAOYSA-N 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 239000007997 Tricine buffer Substances 0.000 description 1
- 240000003864 Ulex europaeus Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000269370 Xenopus <genus> Species 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000006177 biological buffer Substances 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000028956 calcium-mediated signaling Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 230000030570 cellular localization Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- TUESWZZJYCLFNL-DAFODLJHSA-N chembl1301 Chemical compound C1=CC(C(=N)N)=CC=C1\C=C\C1=CC=C(C(N)=N)C=C1O TUESWZZJYCLFNL-DAFODLJHSA-N 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 210000003976 gap junction Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 229950005911 hydroxystilbamidine Drugs 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 239000000138 intercalating agent Substances 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229960000901 mepacrine Drugs 0.000 description 1
- 239000013528 metallic particle Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- DWCZIOOZPIDHAB-UHFFFAOYSA-L methyl green Chemical compound [Cl-].[Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)[N+](C)(C)C)=C1C=CC(=[N+](C)C)C=C1 DWCZIOOZPIDHAB-UHFFFAOYSA-L 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 230000008723 osmotic stress Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000002161 passivation Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000001948 pro-b lymphocyte Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229940043267 rhodamine b Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000004054 semiconductor nanocrystal Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- JSUWTRJITPVDKT-UHFFFAOYSA-N sodium;2,3,4,5-tetrafluorophenol Chemical class [Na].OC1=CC(F)=C(F)C(F)=C1F JSUWTRJITPVDKT-UHFFFAOYSA-N 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical class ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003245 working effect Effects 0.000 description 1
- 239000001043 yellow dye Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0612—Germ cells sorting of gametes, e.g. according to sex or motility
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D19/00—Instruments or methods for reproduction or fertilisation
- A61D19/04—Instruments or methods for reproduction or fertilisation for embryo transplantation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/061—Sperm cells, spermatogonia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Electro-optical investigation, e.g. flow cytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Electro-optical investigation, e.g. flow cytometers
- G01N15/1425—Electro-optical investigation, e.g. flow cytometers using an analyser being characterised by its control arrangement
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G01N15/01—
-
- G01N15/149—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
-
- G01N2015/1028—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Electro-optical investigation, e.g. flow cytometers
- G01N2015/149—Sorting the particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
Definitions
- the invention relates to techniques and systems for visualizing live cells using novel staining procedures.
- the in vivo identification of a target cell population is required, and required quickly, in many industries.
- Such applications include those where the selected cells are destined for other applications that require the cells to be living after identification.
- cells are processed using fluorescence-activated cell sorting, where cells are cultured and expanded in vitro after sorting, or in sperm sorting by gender in animal husbandry applications.
- Distinguishing male-producing from female-producing sperm is most easily accomplished by exploiting the difference in the size of the two sex chromosomes.
- the X chromosome contains more DNA than does the Y chromosome.
- the difference in total DNA between X-bearing sperm and Y-bearing sperm is 3.4% in boar, 3.8% in bull, and 4.2% in ram sperm.
- Fixation procedures often incur artifacts; for example, in the early days of electronic microscopy (EM), multilamellar bodies were observed but were later understood to be mostly by-products of the fixation protocols, not actual structures found in living mammalian cells. While fixation protocols do preserve some of the cell structure, there are many structures that are difficult to preserve, or when preserved tinder appropriate conditions, the rest of the cell architecture is destroyed. Classically, this has been the case for the cytoskeleton, especially for exceptionally dynamic microtubules.
- EM electronic microscopy
- VFPs visible fluorescent proteins
- Green fluorescent protein is a naturally occurring luminescent protein first found in jellyfish. Having been cloned, many variants have been produced that produce a rainbow of colors. In most instances, the protein of interest is fused by recombinant procedures to a VFP of choice and the transgene introduced and expressed in the cell of interest (Chamberlain and Hahn, 2000). While this approach is far superior to previous methods, many extra, time-consuming, steps are required from identifying the protein of interest to actually visualizing it in a living cell.
- the challenge of introducing the dye or stain into a living cells to the appropriate target area is hindered by the cell membrane which provides a barrier to cells from the outside world.
- dyes are membrane impermeant due to their hydrophobic nature or their size; even membrane-permeant dyes can require long incubation times to breach the membrane and reach the target molecules or cellular compartments. Breaching the barrier requires a physical perturbation of the membrane, such as by microinjection or fixation.
- the invention discloses methods for staining cells, such as sperm, including bovine sperm, wherein the sperm are mixed with a dye of choice and then electroporating them to facilitate the introduction of the dye.
- the sperm can be incubated at temperatures that enhance sperm viability, typically equal to or less than 39° C.
- the invention discloses methods for sorting cells, such as sperm, by distinguishing differences in DNA content.
- the cells are stained with a DNA specific dye by mixing the sperm with the dye and then electroporating them.
- the sperm can be maintained at temperatures that enhance sperm viability, typically equal to or less than 39° C.
- the sperm are then passed before an excitation light source causing the stained DNA to fluoresce, and then passed through means for detecting the fluorescence and a means for cell sorting, wherein the cells are sorted by DNA content, and the sorted sperm collected.
- the methods and apparatus are appropriate for mammalian sperm sorting, such as those from bovine, swine, rabbit, alpaca, horse, dog, cat, ferret, rat, mouse and buffalo. Both membrane permeant and impermeant dyes can be used.
- Useful dyes include those from the SYTOX blue, orange and green series, cyanine dimers and monomers, POPO-1, BOBO-1, YOYO-1, TOTO-1, JOJO-1, POPO-3, LOLO-1, BOBO-3, YOYO-3, TOTO-3, PO-PRO-1, BO-PRO-1, YO-PRO-1, TO-PRO-1, JO-PRO-1, PO-PRO-3, LO-PRO-1, BO-PRO-3, YO-PRO-3, TO-PRO-3, TO-PRO-5, acridine homodimer, 7-amino actinomycin D, ethidium bromide, ethidium homodimer-1, ethidium hornodimer-2, ethidium nonazide, nuclear yellow, propidiurn iodide.
- Other useful dyes include those from SYTO 40 blue, green, orange and red fluorescent dyes, Hoechst dyes and dihydroethidium.
- nanoparticles such as quantum dots and metallic nanoparticles, can be introduced.
- the particles can be tagged with targeting molecules. Sorting efficiency can be greater than 90%, while sperm viability rates are greater than 30%, typically greater than 90%.
- the dye is introduced into the cells by osmotic gradients. Cells are first incubated in hypertonic conditions, and then transferred to hypotonic conditions; the DNA-staining dye can be added to either, or both, hypertonic and hypotonic solutions. After dying the cells, they are ready to be sorted or further processed.
- the invention provides methods to pre-select the sex of a mammalian offspring, where the sperm are sorted according to the methods of the invention, and then inseminating a female animal of the same species as the male animal that provided the sperm.
- an egg from a female animal is fertilized in vitro.
- FIG. 1A shows a schematic of an electroporation cell
- FIG. 1B shows a schematic of a Resistance-Capacitator circuit suitable for electroporation.
- FIG. 2 outlines the steps for collecting, sorting and freezing bovine sperm.
- the present invention solves the problem of breaching the cell membrane barrier to introduce cellular stains and nanoparticles without killing the cells.
- populations of millions of living cells can be simultaneously stained and are appropriate for further applications that require living healthy cells because once applied, staining is immediate.
- electroporation or osmotic gradients are used to pemieabilize cell membranes. Electroporation passes an alternating or direct current (AC or DC) electric field over the cells. The electric shock blasts holes into the cell membrane. Under controlled conditions, the size of the holes are big enough to allow introduction of the stain and/or nanoparticles, but small enough to prevent excessive cytosol leakage and irreparable cell damage that results in cell death.
- osmotic pressure gradients are used to partially dehydrate the cells. Cells are incubated in a hypertonic solution and then transferred to a hypotonic solution; in either, or both solutions, the dye is added. As the cells reach osmotic equilibrium with the solution, water flows into the cell, drawing in the dye across the cell membrane.
- the methods of the invention also provide the unexpected result of hastening the diffusion of membrane permeant dyes into cells.
- the methods of the invention also allow the introduction of nanoparticles that can be used as detectable entities in and of themselves (e.g., quantum dots) or to amplify a signal, whether innate to a target molecule or introduced.
- nanoparticles create surface-enhanced resonances, amplifying the natural fluorescence, auto-fluorescence, or fluorescently stained molecules by orders of magnitude.
- Using metallic nanoparticles therefore act as molecular mirrors, deflecting and augmenting available light signals to which they are in close proximity.
- the nanoparticles prevent energy loss of the stimulating radiation to other modes, like phonons, and ensure that the energy is channeled into emitted light.
- the methods of the invention allow for fast live-cell staining, other procedural parameters can be optimized to enhance cell viability. For example, the time during which the cells are mixed with the dye can be reduced or even eliminated, conserving cellular resources. The temperatures at which the cells are manipulated and held can also be reduced, effectuating slower cellular metabolism that again conserves cellular resources.
- the methods are especially appropriate for sorting sperm by gender, in which quick staining of the sperm avoids the problems of reduced viability because of prolonged incubation times.
- Cell-membrane-rupturing-force means force that is sufficient to disrupt a cell membrane such that a cell-impermeant molecule is able to cross the membrane. In the case of cell membrane-permeant molecules, a disrupted membrane permits faster diffusion of the molecule into the cell.
- Comparatively high cell viability rate means a rate wherein at least 5% of the total cell population (e.g., a population of sperm) are alive.
- the rate can be determined by typical viability tests, including exclusion of membrane impermeant dyes (e.g., trypan blue), or for monitoring for a specific cellular activity, such as sperm locomotion.
- DNA-staining dye means a detectable substance that interacts with a polynucleotide such that when examined under appropriate conditions, the polynucleotide is optically detected. While most DNA-staining dyes interact directly with polynucleotides (such as Hoechst stains), DNA-staining dyes also encompass those substances that interact with molecules that interact with polynucleotides, such as those that bind DNA-binding proteins, such as transcription factors and histones. In some instances, DNA-staining dye molecules consist of more than one molecule, such as an antibody tagged with a detectable substance, the antibody specifically binding, for example, a DNA-binding protein.
- Electroporation means a phenomenon in which the membrane of a cell, exposed to short, high intensity electric field pulses, is temporarily destabilized in specific regions of the cell. During the destabilization period, the cell membrane is highly permeable to exogenous molecules present in the surrounding media. Electroporation is one method of providing a cell membrane-rupturing force.
- Hypertonic condition means a condition in which the concentration of electrolyte is above that found in cells in the same solution. In this situation, osmotic pressure leads to the migration of water from the cells to the surrounding solution in an attempt to equalize the electrolyte concentration inside and outside the cell.
- Hypotonic condition means a condition in which the concentration of electrolyte is below that found hi cells in the same solution. In this situation, osmotic pressure leads to the migration of water into the cells in an attempt to equalize the electrolyte concentration inside and outside the cell.
- Nanometallic particle means a nano-scale structure consisting of one or more metals, such as gold, silver, etc.
- Permeating and related terms means to breach a cell membrane. Permeating the cell membrane can be accomplished by electroporation and osmotic stress, just as two examples.
- Quantum dot means a nano-scale crystalline structure, usually made from cadmium selenide, and absorbs white light and then re-emits it a couple of nanoseconds later in a specific color.
- the size of a quantum dot varies within the 10 ⁇ 9 m range, but a quantum dot, regardless of size, is recognizable in that the addition or subtraction of an electron represents a significant change in the particle.
- Targeting molecule means a molecule that has an affinity for another molecule or group of molecules. Examples include antibodies, streptavidin, avidin, biotin, etc.
- Examples include the CUY21EDIT Square Wave Electroporator and SONITRON2000 Sonoporator from Nepa Gene (Ichikawa, Chiba; Japan); the EasyjecT Plus, EasyjecT Optima and EasyjecT-Prima (Flowgen; Nottingham, United Kingdom); Gene Pulser Xcell SystemTM and MicroPulser ElectroporatorTM (BioRad Laboratories; Hercules, Calif.).
- the resistance values range from 2-10,000 ohms ( ⁇ ) depending primarily on the electrical conductivity of the buffer.
- the capacitance varies from 0.1 millifarads (mF) to 1000 mF.
- FIG. 1 One embodiment of a suitable electroporation device is shown in FIG. 1 .
- the electroporation device consists of two parallel glass slides 101 coated with 1,500-2000 angstroms ( ⁇ ) of indium tin oxide, which are separated by fragments of number 0 glass cover slips 102, yielding a slide separation of 100 millimeters (mm).
- the sample cell 103 is connected to a resistor-capacitator (RC) circuit by alligator clips.
- a direct current (DC) power supply 104 is used to charge a capacitor 105 . When a switch is thrown, the discharging capacitor generates a time-dependant and spatially uniform electric field across the sample.
- DC direct current
- An oscilloscope is used to monitor the voltage across the sample cell as a function of time.
- the RC circuit formed by the sample cell and capacitor allow for a well-controlled electric field to be generated.
- the resistance (R) of the circuit is left floating that is, determined by the geometry and content of the sample cell.
- the temperature at which the cells are subjected to electroporation varies with the cell type and the intended application.
- a temperature of about ⁇ 4 ° C. to about 39° C. preferably about 0° C. to about 25° C., more preferably about 0° C. to about 12° C., and most preferably about 0° C., 1° C., 2° C., 3° C., 4° C., 5° C. and 6° C.
- HBSS Hank's Balanced Salt Solution
- BES sodium phosphate-based buffers
- BES sodium phosphate-based buffers
- BES sodium phosphate-based buffers
- BES sodium phosphate-based buffers
- BES sodium phosphate-based buffers
- BES sodium phosphate-based buffers
- BES sodium phosphate-based buffers
- BES sodium phosphate-based buffers
- BES sodium phosphate-based buffers
- BES N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid
- BES-Tris bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane
- EPPS or HEPPS N-(2-hydroxyethyl)piperazine-N′3-propanesulfonic acid
- glyciclycine N-2-hydroxyehtylpiperazine-N′-2-ethanesulfonie acid (HEPES)
- Salt solutions that can be used to produce osmotically appropriate conditions include Alseverr's Solution, Dulbecco's Phosphate Buffered Saline (DPBS), Earle's Balanced Salt Solution, Gey's Balanced Salt Solution (GBSS), Puck's Saline A, Tyrode's Salt Solution, St. Thomas Solution and University of Wisconsin Solution.
- DPBS Dulbecco's Phosphate Buffered Saline
- GBSS Gey's Balanced Salt Solution
- Puck's Saline A Tyrode's Salt Solution
- St. Thomas Solution and University of Wisconsin Solution.
- a simple sucrose solution is sufficient; in others, a simple buffer.
- Cells are harvested according to established procedures, preferably at 4° C. or other metabolic-suspending temperatures, washed, and re-suspended in an osmotically appropriate buffer, preferably without additional divalent cations, such as Ca 2+ , Mg 2+ and Mn 2+ , at a concentration of 1-2 ⁇ 10 7 cells per ml.
- the concentration of the cells can he altered to accommodate the differences in cell size and other variables.
- the desired dye and/or nanoparticles are added to the suspension; the concentrations of which can be experimentally determined.
- an estimate of the appropriate dye concentration can be calculated by using an estimate of the amount of DNA in the sample.
- the cells, dye and/or nanoparticles are incubated in the electroporation cell for a short period of time, e.g., 1-15 minutes, preferably 1-5 minutes, preferably less than 5 minutes, more preferably less than 1 minute, and most preferably 30 seconds at a metabolically-suspending temperature (e.g., 0-4° C.). In other instances, there is no pre-incubation and the cells are electroporated immediately.
- the viscosity of the buffer can be altered to maintain the suspension of particles, such as the addition of a protein (e.g., bovine serum albumin) or inert substance.
- a protein e.g., bovine serum albumin
- the cells, dye and/or nanoparticles are incubated in the electroporation cell for a short period of time after electroporation, e.g., 1-15 minutes, preferably 1-5 minutes, preferably less than 5 minutes, more preferably less than 1 minute, and most preferably 30 seconds at a metabolically-suspending temperature (e.g., 0-4° C.). In other instances, no post-incubation step is necessary.
- a metabolically-suspending temperature e.g., 0-4° C.
- a recovery solution e.g., culture media
- Cells are then transferred for further processing (e.g., washing, collecting, freezing) and observation.
- a recovery media containing divalent cations is preferable, such as provided in appropriate growth media.
- Table 1 presents just one example of an experimental design (adapted from (Potter et al., 1984)); this example is not meant to be limiting. One of skill in the art will know how to manipulate these and other appropriate experimental parameters.
- a pulse of 0.25 seconds at 25 ⁇ F capacitance and 300 V is sufficient in a 1.4 ml electroporation chamber where the electrodes are 4 mm apart (Rieth et al., 2000).
- shorter pulses e.g., approximately 0.25 ms
- lower voltages e.g., approximately 10 V
- Cells or tissue samples that are appropriate for the methods of the invention are collected from a subject or a culture.
- the subject can be a vertebrate, more preferably a mammal, such as a bull, monkey, dog, cat, rabbit, pig, goat, sheep, horse, rat, mouse, guinea pig, etc. Any technique to collect the desired cells may be employed, including biopsy, surgery, scrape (inner cheek, skin, etc.), induced ejaculation (for sperm) and blood withdrawal.
- Any cultured cell type, whether ex vivo cultured cells from a subject, or a cell line, such as Madim-Darby Canine Kidney (MDCK), HeLa, CaCO-2, immunoglobulin-secreting hybridomas, etc. can also be used in the methods of the invention.
- a label can be used.
- the label can be coupled to a binding antibody or other interacting polypeptide, or to one or more particles, such as a nanoparticle.
- Suitable labels include fluorescent moieties, such as fluorescein isothiocyanate; fluorescein dichlorotriazine and fluorinated analogs of fluorescein; naphthofluorescein carboxylic acid and its succinimidyl ester; carboxyrhodamine 6G; pyridyloxazole derivatives; Cy2, 3 and 5; phycoerythrin; fluorescent species of succinimidyl esters, carboxylic acids, isothiocyanates, sulfonyl chlorides, and dansyl chlorides, including propionic acid succinimidyl esters, and pentanoic acid succinimidyl esters; succinimidyl esters of carboxytetramethylihodamine; rhodamine Red-X succinimidyl este
- enzymatic moieties can be appropriate, such as alkaline phosphatase or horseradish peroxidase; and radioactive moieties, including 35 [S] and 135 [I] labels.
- the choice of the label depends on the application, the desired resolution and the desired observation methods.
- fluorescent labels the fluorophore is excited with the appropriate wavelength, and the sample observed using a microscope, confocal microscope, or fluorescence-activate cell sorting (FACS) machine.
- FACS fluorescence-activate cell sorting
- the samples are contacted with autoradiography film and developed; alternatively, autoradiography can also be accomplished using ultrastructural approaches.
- Dyes and stains that are specific for DNA include Hoechst 33342 (2′[4-ethoxyphenyl]-5-[4-methyl-1-piperazinyl]-2,5′-bi-1H-benzimidazole) and Hoechst 33258 (2′[4-ethoxyphenyl]-5-[4-methyl-1-piperazinyl]-2,5′-bi-1H-benzimidazole) and others of the Hoechst series; SYTO 40, SYTO 11, 12, 13, 14, 15, 16, 20, 21, 22, 23, 24, 25 (green); SYTO 17, 59 (red), DAPI, YOYO-1, propidium iodide, YO-PRO-3, TO-PRO-3, YOYO-3 and TOTO-3, SYTOX Green, SYTOX, methyl green, acridine homodimer,
- a physical characteristic of that molecule can be used, such as the innate autofluorescence in DNA.
- signal intensity can be modulated by the introduction of nanoparticles (see Modulating fluorescence signals with nanoparticles, below).
- the modulation of the concentration of solutes can create an environment that is either hypertonic or hypotonic to cells.
- a hypertonic solution By suspending the cells in a hypertonic solution, cells become partially dehydrated. After a short period, they are then transferred to a hypotonic solution.
- Either, or both solutions can include the dye of interest, but should be present to be available to the cells to enter the cells.
- the dye is present in at least the hypotonic solution.
- Osmolality can be varied by either adding appropriate salts or other solutes that are compatible with the cells of interest (e.g., KCl, NaCl, MgCl 2 , MnCl 2 , CaCl 2 , sucrose, glucose, etc.), or by diluting the solution with water or buffer.
- cells are transferred to a hypertonic solution for about 0 to about 15 minutes, preferably, about 1 to about10 minutes, more preferably about 3 to about 7 minutes, and most preferably about 5 minutes.
- the temperature of the solution is about ⁇ 4° C. to about 39° C., preferably about 0° C. to about 25° C., more preferably 0° C. to about 12° C., and most preferably, about 4° C.
- the cells are then transferred to a hypotonic solution or the solution in which the cells are in is diluted with buffer to create hypotonic conditions.
- the temperature of the added solution is bout ⁇ 4° C. to about 39° C., preferably about 0° C. to about 25′′ C, more preferably 0° C. to about 12° C., and most preferably, about 4° C.
- Osmolality conditions vary somewhat by cell type. However, for bovine sperm, hypertonic conditions are created at approximately greater than 250 mOsm, whereas hypotonic conditions are created at approximately less than 250 mOsm (Liu and Foote, 1998).
- Preferred hypertonic osmalities include 100 mOsm to 249 mOsm; most preferably greater than 150 mOsm, but less than 250 mOsm.
- Hypotonic osmalities include 251 mOsm to 1537 mOsm; preferably 500 mOsm to 963 mOsm; and most preferably greater than 250 mOsm but less than 732 mOsm.
- the dye can be any of those listed in Tables 2-4 or other appropriate dye.
- QDs quantum dots
- the core of a QD consists of a semiconductor nanocrystal, such as CdSe, surrounded by a passivation shell, such as ZuS.
- a passivation shell such as ZuS.
- This energy, and therefore the wavelength, is dependent on the size of the core (smaller->lower wavelength), which can be varied almost at will by controlled-synthesis conditions (Lidke and Amdt-Jovin, 2004).
- the surface is coated with a polymer that protects the QD from water and allows for chemical coupling to molecules.
- the excitation spectra of QDs are a continuum, rising into the ultraviolet, and the emission spectra are narrow and slightly red-shifted to the band-gap absorption. Thus QDs with different emissions can be excited with a single excitation (Smith and Nie, 2004).
- the large extinction coefficient and the relatively high quantum yield of QDs, as well as their extraordinary photostability, permit the use of a low sample irradiance and prolonged imaging with a detection sensitivity extending down to the single-QD level.
- QDs are commercially available (e.g., Quantum Dot Corp.; Hayward, Calif. and Evident Technologies; Troy, N.Y.) with a variety of conjugated or reactive surfaces, e.g., amino, carboxyl, streptavidin, protein A, biotin, and immunoglobulins.
- QDs are non-toxic to most cells. For example, tissue culture cells loaded with QDs survive for weeks without diminished growth or division, and the Q:Ds persisted the entire time (Doty et al., 2004). In live animal studies, mice lived normal lives with QDs for months without obvious deleterious effects (Lidke and Arndt-Jovin, 2004).
- QDs can be introduced into sexual reproductive cells without harm. For example, Xenopus embryos injected with QDs did not alter the subsequent phenotype; the QDs were viewable throughout development (Smith and Nie, 2004).
- QDs can be targeted to specific areas of the cell, such as the nucleus, by coating them with appropriate molecules, such as DNA-binding molecules (oligonucleotides, DNA-binding proteins, such as histones, transcription factors, polymerases and other molecules of the chromatin, DNA-binding dyes, such as those listed in Tables 2-4, or other small molecules, such as other base intercalators).
- DNA-binding molecules oligonucleotides, DNA-binding proteins, such as histones, transcription factors, polymerases and other molecules of the chromatin
- DNA-binding dyes such as those listed in Tables 2-4, or other small molecules, such as other base intercalators.
- metallic nano-particles can be used to enhance any fluorescent signal, such as those made of gold and silver. They can likewise be tagged with targeting molecules such that they are in close proximity of the stained DNA.
- an indicator that has a strongly non-linear response to DNA amount facilitates measuring DNA content
- this indicator has very little or no fluorescence for the amount of DNA associated with one chromosome, and large amounts of fluorescence for the amount of DNA associated with another chromosome, although in practice approximations to this non-linear response curve are extremely useful.
- Photo-activated fluorophores are one such mechanism . Incorporating a photo-activated fluorophore which has a non-linear response to the usual fluorescence emitted by a DNA stain provides a flexible combination of fluorophores whose properties may be tuned to achieve the desired non-linearity (Hogan, 2005).
- Such photo-activated fluorophores would not necessarily have to be incorporated into the nucleus of the sperm as they may be tuned to respond to fluorescence from the sperm as a whole.
- molecular or nano-transistors into the medium or the sperm, they act as non-linear amplifiers for fluorescence radiated from DNA, either innate autofluorescence or that generated from a stain,
- nano-transistors have countless embodiments because they can be based on biological proteins, or based on quantum dot transistors.
- Nearby conducing metallic particles, colloids or surfaces can modify free-space spectral conditions of fluorophores such that the incident electric field “felt” by the. fluorophore is increased (or decreased), and the rate of radiavity decay can also be modulated (Asian et al., 2004).
- the radiavity decay rate is that at which a fluorophore emits photons.
- particles can be tagged with fluorescent molecules; or, in the case of polynucleotides (which have a low level of auto fluorescence at 260 nm and 280 nm), tagged with molecules that bind the polynucleotides, such as oligonucleotides, small molecules, or polynucleotide specific binding polypeptides.
- the particles are suspended with the cells prior to electroporation.
- Flow cytometry measures of cells as they flow by a detector
- Flow cytometers use focused laser light to illuminate cells as they pass the laser beam, one at a time, in a fine fluid stream.
- Light scattered by the cells and light emitted by fluorescent dyes attached or loaded in the cells are analyzed by detectors.
- Cells can be distinguished and selected on the basis of size and shape, as well as by the presence of different molecules inside and on the surface of the cells.
- FIG. 2 outlines the flow that can be applied to gender-sorting of sperm.
- the sperm are collected from the donor 201 and subjected to extension 202 and then cooled slowly to 6° C. Once cooled, the sperm can be subjected to staining DNA by any technique, but preferably the novel techniques of the present invention, using electroporation or osmolality andior nanoparticles of various compositions.
- the stained cells are introduced into a cell sorting device 204 and separated based on gender difference, usually by the sex chromosomes X and Y.
- the sorted cells are collected, and slowly cooled to 4° C. 205 before being subjected to a final extension 206 .
- the cells are loaded into cryogenic-compatible straws 207 , the cell allowed to settle 208 , and then frozen 209 .
- the cells may be cooled to greater than 6° C. as shown in step 203 .
- Sorting itself 204 can also take place at cooler temperatures, thus preserving cell integrity and cell viability.
- eggs, egg yolks or other sperm-supporting substances are added to the collected sperm to improve viability; however, because the present invention allows for staining and sorting of the cells at cool temperatures 9 —those in which the cells are metabolically inactive, or nearly so (“metabolically suspended”)—such a step (and the potential of introducing a confounding variable in sorting, being obliged to pre-filter before sorting, and potentially contaminating the sample with microbes) can be eliminated, or the quantity of added egg or other sperm-supporting substances can be reduced to facilitate sorting and other processing.
- dead cells and successfully stained, viable cells both fluoresce. This is because dead cells have compromised cell membranes.
- a counter-stain that diminishes the signal For example, in sperm, membrane-impermeant red food coloring is mixed with the cells. By first dyeing the sperm with an impermeable dye, the Hoechst dye is not able to bind to the DNA since the impermeable dye is already bound. Therefore, the fluorescence of the dead sperm should be either eliminated or a different color, depending on the impermeable DNA dye used. Other classic tests include Trypan blue exclusion, where only non-viable cells allow entry of the dye, diminishing fluorescent signals. In this case, the dye is added after electroporation or osmotic shock, but before sorting.
- Electroporation unit A sample cell was formed by two parallel glass slides coated with 1,500-2000 angstroms ( ⁇ ) of indium tin oxide (ITO). The slides were separated by fragments of number zero glass cover slips, yielding a slide separation of 100 millimeters (mm).
- ITO indium tin oxide
- the sample cell was connected to a resistor-capacitator (RC) circuit by alligator clips.
- a direct current (DC) power supply was used to charge a capacitor.
- the discharging capacitor generated a time-dependant and spatially uniform electric field across the sample.
- An oscilloscope was used to monitor the voltage across the sample cell as a function of time.
- the RC circuit formed by the sample cell and capacitor allowed for a well-controlled electric field to be generated.
- the resistance (R) of the circuit was left floating—that is, determined by the geometry and content of the sample cell. Typical R values ranged from 2-10,000 watts (W) depending primarily on the electrical conductivity of the buffer.
- the capacitance was varied from 0.1 millifarads (mF) to 1000 mF.
- Electroporation A voltage was applied to the capacitor circuit, and then the power supply was disconnected. A switch was then thrown and the capacitor discharged across the sample cell. These steps were carried out within 15 seconds of transferring the sperm to the sample cell to retain a random orientation of sperm with respect to the electric field. Electroporation was carried out on sperm in isotonic (0.25 M sucrose) and hypertonic (0.35 M sucrose) solutions. In each case, 10 V was applied to the capacitor and a time constant of 0.26 milliseconds (ms) measured.
- Motility was examined in the hypertonic/hypotonic solution and compared to a control sample unexposed to an electric field.
- the electroporated sample yielded a loss of 70% of motile sperm compared to the control.
- the electroporated sample showed a 68% increase in the number of damaged and non-motile sperm. All of the observed motile sperm in the hypertonicihypotonic solution exposed to the electric field displayed fluorescence.
- a temporary spatially uniform electric field allows non-permeant membrane dyes to cross bovine sperm cell membranes.
- a 70% loss in motility was associated with this process—but manipulating procedure parameters can reduce the death toll.
- This technique also allows for the introduction of nanoparticles into sperm and other membrane bound-cells.
Abstract
Description
- This application incorporates by reference the related application, METHOD AND APPARATUS FOR SORTING CELLS, Ser. No. ______, filed ______, and Representative Docket Number 089000-0138.
- Not Applicable.
- Not Applicable.
- The invention relates to techniques and systems for visualizing live cells using novel staining procedures.
- The in vivo identification of a target cell population is required, and required quickly, in many industries. Such applications include those where the selected cells are destined for other applications that require the cells to be living after identification. For example, cells are processed using fluorescence-activated cell sorting, where cells are cultured and expanded in vitro after sorting, or in sperm sorting by gender in animal husbandry applications.
- Being able to pre-select animal offspring gender would allow more efficient operations of livestock producers. Dairy farmers have little use for most bull calves. For example, males are preferred in beef cattle and sheep because males grow faster, producing more meat more quickly.
- The male reproductive cells, the sperm, determine the gender of the offspring. Most males carry an X and a Y sex chromosome, whereas females carry two X chromosomes. A sperm or an egg contains one half of that parent's genetic information; however, the egg only carries an X chromosome one of each pair of autosomes. In mammals, the egg always contains an X chromosome, while the sperm carries either an X or Y chromosome.
- Distinguishing male-producing from female-producing sperm is most easily accomplished by exploiting the difference in the size of the two sex chromosomes. The X chromosome contains more DNA than does the Y chromosome. For example, the difference in total DNA between X-bearing sperm and Y-bearing sperm is 3.4% in boar, 3.8% in bull, and 4.2% in ram sperm.
- Distinguishing Cells
- To illuminate the workings of cells or distinguish cells that differ from each other by the slightest difference (e.g., expression of a particular molecule), various visualization methods have been used for decades, from simple light microscopic observations to high-voltage electronic microscopy. In most of these techniques, cells or tissue are preserved, usually using a cross-linking agent such as an aldehyde (proteins, e.g., glutaraldehyde and formaldehyde), osmium (lipids) or by precipitating parts of the cells, such as cold methanol and proteins. These techniques suffer from the preparation processes that allow for the visualization. Fixation procedures often incur artifacts; for example, in the early days of electronic microscopy (EM), multilamellar bodies were observed but were later understood to be mostly by-products of the fixation protocols, not actual structures found in living mammalian cells. While fixation protocols do preserve some of the cell structure, there are many structures that are difficult to preserve, or when preserved tinder appropriate conditions, the rest of the cell architecture is destroyed. Classically, this has been the case for the cytoskeleton, especially for exceptionally dynamic microtubules.
- To overcome the limitations of visualization techniques in fixed samples, “in vivo” approaches have been explored. For example, to understand where native polypeptides localize, those polypeptides have been purified, associated with a detectable dye (usually covalently), and then introduced into the cell of interest and observed (Chamberlain and Hahn, 2000). This approach does offer the advantages of non-fixed cells; however, the time and expense to purify a target polypeptide, conjugate it to a dye, and then to microinject (a task requiring specialized equipment, experience, skill and patience) the complex into a cell often outweigh the advantages. Furthermore, only limited numbers of cells could be examined at any given time due to the limitations of microinjection.
- With the advent of the discovery of green and other visible fluorescent proteins (VFPs), however, the ability to visualize polypeptides—even polypeptide-polypeptide interactions—became facile and less riddled with artifacts. Green fluorescent protein is a naturally occurring luminescent protein first found in jellyfish. Having been cloned, many variants have been produced that produce a rainbow of colors. In most instances, the protein of interest is fused by recombinant procedures to a VFP of choice and the transgene introduced and expressed in the cell of interest (Chamberlain and Hahn, 2000). While this approach is far superior to previous methods, many extra, time-consuming, steps are required from identifying the protein of interest to actually visualizing it in a living cell.
- Going beyond cellular localization and movement of proteins, other dyes have been exploited to identify other processes or stain specific molecules. For example, calcium-mediated signaling is monitored in living cells using the fura series of dyes. Other fluorescent dyes have been used to test the molecular size barriers of gap junctions in, for example, epithelial cells. Finally, other stains target specific molecules, such as double-stranded deoxyribonucleic acid (DNA); such stains include some of the Hoechst series of dyes, propidium iodide and ethidium bromide.
- In each case, however, the challenge of introducing the dye or stain into a living cells to the appropriate target area is hindered by the cell membrane which provides a barrier to cells from the outside world. In many cases, dyes are membrane impermeant due to their hydrophobic nature or their size; even membrane-permeant dyes can require long incubation times to breach the membrane and reach the target molecules or cellular compartments. Breaching the barrier requires a physical perturbation of the membrane, such as by microinjection or fixation.
- Available procedures are few and when available, often face uncompromising challenges. Even traditional methods of staining DNA in common methods of sorting sperm cells by gender require extensive incubation times at elevated temperatures (e.g., 60 minutes at 35° C.; (Johnson, 1992)), permitting quality degradation of the cells. In addition, staining must be sufficient so that the signal can be accurately and precisely detected.
- In a first aspect, the invention discloses methods for staining cells, such as sperm, including bovine sperm, wherein the sperm are mixed with a dye of choice and then electroporating them to facilitate the introduction of the dye. The sperm can be incubated at temperatures that enhance sperm viability, typically equal to or less than 39° C.
- In a second aspect, the invention discloses methods for sorting cells, such as sperm, by distinguishing differences in DNA content. The cells are stained with a DNA specific dye by mixing the sperm with the dye and then electroporating them. The sperm can be maintained at temperatures that enhance sperm viability, typically equal to or less than 39° C. The sperm are then passed before an excitation light source causing the stained DNA to fluoresce, and then passed through means for detecting the fluorescence and a means for cell sorting, wherein the cells are sorted by DNA content, and the sorted sperm collected. The methods and apparatus are appropriate for mammalian sperm sorting, such as those from bovine, swine, rabbit, alpaca, horse, dog, cat, ferret, rat, mouse and buffalo. Both membrane permeant and impermeant dyes can be used. Useful dyes include those from the SYTOX blue, orange and green series, cyanine dimers and monomers, POPO-1, BOBO-1, YOYO-1, TOTO-1, JOJO-1, POPO-3, LOLO-1, BOBO-3, YOYO-3, TOTO-3, PO-PRO-1, BO-PRO-1, YO-PRO-1, TO-PRO-1, JO-PRO-1, PO-PRO-3, LO-PRO-1, BO-PRO-3, YO-PRO-3, TO-PRO-3, TO-PRO-5, acridine homodimer, 7-amino actinomycin D, ethidium bromide, ethidium homodimer-1, ethidium hornodimer-2, ethidium nonazide, nuclear yellow, propidiurn iodide. Other useful dyes include those from SYTO 40 blue, green, orange and red fluorescent dyes, Hoechst dyes and dihydroethidium. To enhance the signal, nanoparticles, such as quantum dots and metallic nanoparticles, can be introduced. The particles can be tagged with targeting molecules. Sorting efficiency can be greater than 90%, while sperm viability rates are greater than 30%, typically greater than 90%. Alternatively, instead of electroporating the cells, the dye is introduced into the cells by osmotic gradients. Cells are first incubated in hypertonic conditions, and then transferred to hypotonic conditions; the DNA-staining dye can be added to either, or both, hypertonic and hypotonic solutions. After dying the cells, they are ready to be sorted or further processed.
- In a third aspect, the invention provides methods to pre-select the sex of a mammalian offspring, where the sperm are sorted according to the methods of the invention, and then inseminating a female animal of the same species as the male animal that provided the sperm. In a fourth aspect, instead of inseminating a female animal, an egg from a female animal is fertilized in vitro.
-
FIG. 1A shows a schematic of an electroporation cell -
FIG. 1B shows a schematic of a Resistance-Capacitator circuit suitable for electroporation. -
FIG. 2 outlines the steps for collecting, sorting and freezing bovine sperm. - While the present invention is susceptible of embodiment in many different forms, there are shown in the drawings and described herein in detail specific embodiments thereof, with the understanding that the present disclosure is to be considered as an exemplification of the principles of the invention and is not intended to limit the invention to the specific embodiments illustrated.
- The present invention solves the problem of breaching the cell membrane barrier to introduce cellular stains and nanoparticles without killing the cells. Using the methods of the invention, populations of millions of living cells can be simultaneously stained and are appropriate for further applications that require living healthy cells because once applied, staining is immediate.
- In some embodiments of the invention, electroporation or osmotic gradients are used to pemieabilize cell membranes. Electroporation passes an alternating or direct current (AC or DC) electric field over the cells. The electric shock blasts holes into the cell membrane. Under controlled conditions, the size of the holes are big enough to allow introduction of the stain and/or nanoparticles, but small enough to prevent excessive cytosol leakage and irreparable cell damage that results in cell death. Alternatively, osmotic pressure gradients are used to partially dehydrate the cells. Cells are incubated in a hypertonic solution and then transferred to a hypotonic solution; in either, or both solutions, the dye is added. As the cells reach osmotic equilibrium with the solution, water flows into the cell, drawing in the dye across the cell membrane.
- The methods of the invention also provide the unexpected result of hastening the diffusion of membrane permeant dyes into cells.
- In addition to introducing stains and dyes into living cells, the methods of the invention also allow the introduction of nanoparticles that can be used as detectable entities in and of themselves (e.g., quantum dots) or to amplify a signal, whether innate to a target molecule or introduced. For example, metallic nanoparticles create surface-enhanced resonances, amplifying the natural fluorescence, auto-fluorescence, or fluorescently stained molecules by orders of magnitude. Using metallic nanoparticles therefore act as molecular mirrors, deflecting and augmenting available light signals to which they are in close proximity. The nanoparticles prevent energy loss of the stimulating radiation to other modes, like phonons, and ensure that the energy is channeled into emitted light. Because the natural fluorescence intensity of some target molecules, such as DNA, is normally very low, amplification the available signal reduces reliance on dyes or stains which can interfere with normal functioning of the target molecule. For example, many DNA-specific dyes intercalate between the bases; this intercalation can, in mitotically or meiotically active cells, introduce mutations into the genetic code.
- Since the methods of the invention allow for fast live-cell staining, other procedural parameters can be optimized to enhance cell viability. For example, the time during which the cells are mixed with the dye can be reduced or even eliminated, conserving cellular resources. The temperatures at which the cells are manipulated and held can also be reduced, effectuating slower cellular metabolism that again conserves cellular resources.
- The methods are especially appropriate for sorting sperm by gender, in which quick staining of the sperm avoids the problems of reduced viability because of prolonged incubation times.
- Definitions
- Cell-membrane-rupturing-force means force that is sufficient to disrupt a cell membrane such that a cell-impermeant molecule is able to cross the membrane. In the case of cell membrane-permeant molecules, a disrupted membrane permits faster diffusion of the molecule into the cell.
- Comparatively high cell viability rate means a rate wherein at least 5% of the total cell population (e.g., a population of sperm) are alive. The rate can be determined by typical viability tests, including exclusion of membrane impermeant dyes (e.g., trypan blue), or for monitoring for a specific cellular activity, such as sperm locomotion.
- DNA-staining dye means a detectable substance that interacts with a polynucleotide such that when examined under appropriate conditions, the polynucleotide is optically detected. While most DNA-staining dyes interact directly with polynucleotides (such as Hoechst stains), DNA-staining dyes also encompass those substances that interact with molecules that interact with polynucleotides, such as those that bind DNA-binding proteins, such as transcription factors and histones. In some instances, DNA-staining dye molecules consist of more than one molecule, such as an antibody tagged with a detectable substance, the antibody specifically binding, for example, a DNA-binding protein.
- Electroporation means a phenomenon in which the membrane of a cell, exposed to short, high intensity electric field pulses, is temporarily destabilized in specific regions of the cell. During the destabilization period, the cell membrane is highly permeable to exogenous molecules present in the surrounding media. Electroporation is one method of providing a cell membrane-rupturing force.
- Hypertonic condition means a condition in which the concentration of electrolyte is above that found in cells in the same solution. In this situation, osmotic pressure leads to the migration of water from the cells to the surrounding solution in an attempt to equalize the electrolyte concentration inside and outside the cell.
- Hypotonic condition means a condition in which the concentration of electrolyte is below that found hi cells in the same solution. In this situation, osmotic pressure leads to the migration of water into the cells in an attempt to equalize the electrolyte concentration inside and outside the cell.
- Nanometallic particle means a nano-scale structure consisting of one or more metals, such as gold, silver, etc.
- Permeating and related terms means to breach a cell membrane. Permeating the cell membrane can be accomplished by electroporation and osmotic stress, just as two examples.
- Quantum dot means a nano-scale crystalline structure, usually made from cadmium selenide, and absorbs white light and then re-emits it a couple of nanoseconds later in a specific color. The size of a quantum dot varies within the 10−9 m range, but a quantum dot, regardless of size, is recognizable in that the addition or subtraction of an electron represents a significant change in the particle.
- Targeting molecule means a molecule that has an affinity for another molecule or group of molecules. Examples include antibodies, streptavidin, avidin, biotin, etc.
- Making and Using the Invention
- Electroporation
- When a short, high-voltage pulse surpasses the capacitance of a cell membrane, transient—and reversible—disruption of a cell membrane occurs (Gehl, 2003). This disruption allows for easier diffusion of small molecules into the cell, as well as for electrophoretically driving molecules through the destabilized membrane (Gehl, 2003). Any electroporation (an electroporator) or other cell membrane-rupturing-force device which parameters can be manipulated as necessary by the user can be used in the methods of the invention. Examples include the CUY21EDIT Square Wave Electroporator and SONITRON2000 Sonoporator from Nepa Gene (Ichikawa, Chiba; Japan); the EasyjecT Plus, EasyjecT Optima and EasyjecT-Prima (Flowgen; Nottingham, United Kingdom); Gene Pulser Xcell System™ and MicroPulser Electroporator™ (BioRad Laboratories; Hercules, Calif.). Typically, the resistance values range from 2-10,000 ohms (Ω) depending primarily on the electrical conductivity of the buffer. The capacitance varies from 0.1 millifarads (mF) to 1000 mF.
- One embodiment of a suitable electroporation device is shown in
FIG. 1 . Referring toFIG. 1A , the electroporation device consists of two parallel glass slides 101 coated with 1,500-2000 angstroms (Å) of indium tin oxide, which are separated by fragments of number 0 glass cover slips 102, yielding a slide separation of 100 millimeters (mm). Referring now to the circuit inFIG. 1B , thesample cell 103 is connected to a resistor-capacitator (RC) circuit by alligator clips. A direct current (DC)power supply 104 is used to charge acapacitor 105. When a switch is thrown, the discharging capacitor generates a time-dependant and spatially uniform electric field across the sample. An oscilloscope is used to monitor the voltage across the sample cell as a function of time. The RC circuit formed by the sample cell and capacitor allow for a well-controlled electric field to be generated. The resistance (R) of the circuit is left floating that is, determined by the geometry and content of the sample cell. - The temperature at which the cells are subjected to electroporation varies with the cell type and the intended application. For example, in the case of staining mammalian sperm cells for sorting by gender, such as those from bovines, a temperature of about −4 ° C. to about 39° C.; preferably about 0° C. to about 25° C., more preferably about 0° C. to about 12° C., and most preferably about 0° C., 1° C., 2° C., 3° C., 4° C., 5° C. and 6° C.
- Cells are suspended in an osmotically appropriate buffer for electroporation, although the solution can be hyper- or hypotonic to increase the efficiency of electroporation. For example, a 0.35 M sucrose solution yields good results for bovine sperm. Appropriate biological buffers include Hank's Balanced Salt Solution (HBSS), sodium phosphate-based buffers, N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid (BES), bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane (BIS-Tris), N-(2-hydroxyethyl)piperazine-N′3-propanesulfonic acid (EPPS or HEPPS), glyciclycine, N-2-hydroxyehtylpiperazine-N′-2-ethanesulfonie acid (HEPES), 3-(N-morpholino)propane sulfonie acid (MOPS), piperazine-N,N′-bis(2-ethane-sulfonic acid) (PIPES), sodium bicarbonate, 3-(N-tris(hydroxymethyl)-methyl-amino)-2-hydroxy-propariesulfonic acid) TAPSO, (N-tris(hydroxyrnethyl)methyl-2-aminoethanesulfonic acid (TES), N-tris(hydroxymethyl)methyl-glycine (Tricine), and tris(hydroxymethyl)-aminomethane (Tris). Salt solutions that can be used to produce osmotically appropriate conditions include Alseverr's Solution, Dulbecco's Phosphate Buffered Saline (DPBS), Earle's Balanced Salt Solution, Gey's Balanced Salt Solution (GBSS), Puck's Saline A, Tyrode's Salt Solution, St. Thomas Solution and University of Wisconsin Solution. In some instances, a simple sucrose solution is sufficient; in others, a simple buffer.
- Because cells differ from organism to organism, of even the same cell type, the parameters for electroporation may need to be determined experimentally. An assay is provided to determine the appropriate parameters for each cell type.
- Assay to Determine Parameters for Electroporation Introduction of Dyes and Nanoparticles
- Cells are harvested according to established procedures, preferably at 4° C. or other metabolic-suspending temperatures, washed, and re-suspended in an osmotically appropriate buffer, preferably without additional divalent cations, such as Ca2+, Mg2+ and Mn2+, at a concentration of 1-2×107 cells per ml. The concentration of the cells can he altered to accommodate the differences in cell size and other variables. The desired dye and/or nanoparticles are added to the suspension; the concentrations of which can be experimentally determined. In the case of dyes wherein the binding sites are known (e.g., intercalation between adenosine and threonine in DNA), an estimate of the appropriate dye concentration can be calculated by using an estimate of the amount of DNA in the sample. In sonic cases, the cells, dye and/or nanoparticles are incubated in the electroporation cell for a short period of time, e.g., 1-15 minutes, preferably 1-5 minutes, preferably less than 5 minutes, more preferably less than 1 minute, and most preferably 30 seconds at a metabolically-suspending temperature (e.g., 0-4° C.). In other instances, there is no pre-incubation and the cells are electroporated immediately. In the case of nanoparticles, incubation times are minimized to prevent any settling or non random dispersion of the particles. Alternatively, the viscosity of the buffer can be altered to maintain the suspension of particles, such as the addition of a protein (e.g., bovine serum albumin) or inert substance.
- An electric pulse is applied; a starting voltage of 2.0 kV represents a reasonable starting point, with the current set at a maximum of 0.9 mA. Adjustable current and wattage dials are set at bare minimum. In some cases, the cells, dye and/or nanoparticles are incubated in the electroporation cell for a short period of time after electroporation, e.g., 1-15 minutes, preferably 1-5 minutes, preferably less than 5 minutes, more preferably less than 1 minute, and most preferably 30 seconds at a metabolically-suspending temperature (e.g., 0-4° C.). In other instances, no post-incubation step is necessary. For other cell types, restoring physiological conditions is paramount to preserve cell viability; for these cells, a recovery solution (e.g., culture media) is added immediately. Cells are then transferred for further processing (e.g., washing, collecting, freezing) and observation. In most cases, a recovery media containing divalent cations is preferable, such as provided in appropriate growth media.
- Table 1 presents just one example of an experimental design (adapted from (Potter et al., 1984)); this example is not meant to be limiting. One of skill in the art will know how to manipulate these and other appropriate experimental parameters.
-
TABLE 1 Example of experimental parameters for determining transfer frequency by electroporation Power supply Temperature Cells settings (kV/mA) Electrode (° C.) A 1.2/300 Al 20 A 1.2/300 Al 20 Temperature and voltage effects A 1.2/300 Al 20 A 1.2/300 Al 0 A 1.2/300 Al 20 A 4.0/0.9 Al 20 A 4.0/capacitor Al 20 A 1.2/100 SS 20 A 1.2/100 ss 0 A 1.2/300 SS 0 A 2.0/0.9 ss 0 A 4.0/capacitor ss 0 Comparison of cell lines and species A 4.0/0.9 Al 0 B 4.0/0.9 Al 0 C 4.0/0.9 Al 0 D 4.0/0.9 Al 0 - For bovine sperm, when introducing macromolecules such as DNA, a pulse of 0.25 seconds at 25 μF capacitance and 300 V is sufficient in a 1.4 ml electroporation chamber where the electrodes are 4 mm apart (Rieth et al., 2000). For smaller molecules, shorter pulses (e.g., approximately 0.25 ms) at lower voltages (e,g., approximately 10 V) can be used (see Example 1).
- Cells
- Cells or tissue samples that are appropriate for the methods of the invention are collected from a subject or a culture. The subject can be a vertebrate, more preferably a mammal, such as a bull, monkey, dog, cat, rabbit, pig, goat, sheep, horse, rat, mouse, guinea pig, etc. Any technique to collect the desired cells may be employed, including biopsy, surgery, scrape (inner cheek, skin, etc.), induced ejaculation (for sperm) and blood withdrawal. Any cultured cell type, whether ex vivo cultured cells from a subject, or a cell line, such as Madim-Darby Canine Kidney (MDCK), HeLa, CaCO-2, immunoglobulin-secreting hybridomas, etc. can also be used in the methods of the invention.
- Stains, Dyes and Other Visual Labels
- To detect a molecule of interest, a label can be used. The label can be coupled to a binding antibody or other interacting polypeptide, or to one or more particles, such as a nanoparticle. Suitable labels include fluorescent moieties, such as fluorescein isothiocyanate; fluorescein dichlorotriazine and fluorinated analogs of fluorescein; naphthofluorescein carboxylic acid and its succinimidyl ester; carboxyrhodamine 6G; pyridyloxazole derivatives; Cy2, 3 and 5; phycoerythrin; fluorescent species of succinimidyl esters, carboxylic acids, isothiocyanates, sulfonyl chlorides, and dansyl chlorides, including propionic acid succinimidyl esters, and pentanoic acid succinimidyl esters; succinimidyl esters of carboxytetramethylihodamine; rhodamine Red-X succinimidyl ester; Texas Red sulfonyl chloride; Texas Red-X succinimidyl ester; Texas Red-X sodium tetrafluorophenol ester; Red-X; Texas Red dyes; tetramethylrhodamine; lissarnine rhodamine B; tetramethylrhodamine; tetramethylrhodamine isothiocyanate; naphthofluoresceins; coumarin derivatives; pyreries; pyridyloxazole derivatives; dapoxyl dyes; Cascade Blue and Yellow dyes; benzofuran isothiocyanates; sodium tetrafluorophenols; 4,4-difluoro-4-bora-3a,4a-dia-za-s-indacene. In some cases enzymatic moieties can be appropriate, such as alkaline phosphatase or horseradish peroxidase; and radioactive moieties, including 35[S] and 135[I] labels. The choice of the label depends on the application, the desired resolution and the desired observation methods. For fluorescent labels, the fluorophore is excited with the appropriate wavelength, and the sample observed using a microscope, confocal microscope, or fluorescence-activate cell sorting (FACS) machine. In the case of radioactive labeling, the samples are contacted with autoradiography film and developed; alternatively, autoradiography can also be accomplished using ultrastructural approaches.
- Dyes and stains that are specific for DNA (or preferentially bind double stranded polynucleotides in contrast to single-stranded polynucleotides) include Hoechst 33342 (2′[4-ethoxyphenyl]-5-[4-methyl-1-piperazinyl]-2,5′-bi-1H-benzimidazole) and Hoechst 33258 (2′[4-ethoxyphenyl]-5-[4-methyl-1-piperazinyl]-2,5′-bi-1H-benzimidazole) and others of the Hoechst series; SYTO 40, SYTO 11, 12, 13, 14, 15, 16, 20, 21, 22, 23, 24, 25 (green); SYTO 17, 59 (red), DAPI, YOYO-1, propidium iodide, YO-PRO-3, TO-PRO-3, YOYO-3 and TOTO-3, SYTOX Green, SYTOX, methyl green, acridine homodimer, 7-aminoactinomycin D, 9-amino-6-chloro-2-methoxyactridine. Tables 1, 2 and 3 list many of the available polynucleotides-specific/chromosome specific stains currently available (Tables 2-4 have been adapted from (Haugland, 2002)).
-
TABLE 2 Cell membrane-impermeant cyanine nucleic acid stains Excitation Catalogue #1 Dye Name Ex/Em * Source † SYTOX Dyes S11348 SYTOX Blue 445/470 Hg-arc lamp, 436 nm line S7020 SYTOX Green 504/523 Ar-ion laser, 488 nm line S11368 SYTOX Orange 547/570 Nd: YAG laser, 532 nm line Cyanine Dimers P3580 POPO-1 434/456 Hg-arc lamp, 436 nm line He—Cd laser, 442 nm line B3582 BOBO-1 462/481 Hg-arc lamp, 436 nm line He—Cd laser, 442 nm line Y3601 YOYO-1 491/509 Ar-ion laser, 488 nm line T3600 TOTO-1 514/533 Ar-ion laser, 514 nm line J11372 JOJO-1 529/545 Nd: YAG laser, 532 nm line P3584 POPO-3 534/570 Nd: YAG laser, 532 nm line L11376 LOLO-1 565/579 Kr-ion laser, 568 nm line B3586 BOBO-3 570/602 Hg-arc lamp, 578 nm line Y3606 YOYO-3 612/631 Orange He—Ne laser, 594 nm line T3604 TOTO-3 642/660 He—Ne laser, 633 nm line Kr-ion laser, 647 nm line 635 nm diode laser Cyanine Monomers P3581 PO-PRO-1 435/455 Hg-arc lamp, 436 nm line He—Cd laser, 442 nm line B3583 BO-PRO-1 462/481 Hg-arc lamp, 436 nm line He—Cd laser, 442 nm line Y3603 YO-PRO-1 491/509 Ar-ion laser, 488 nm line T3602 TO-PRO-1 515/531 Ar-ion laser, 514 nm line J11373 JO-PRO-1 530/546 Nd: YAG laser, 532 nm line P3585 PO-PRO-3 539/567 Nd: YAG laser, 532 nm line He—Ne laser, 543 nm line L11377 LO-PRO-1 567/580 Kr-ion laser, 568 nm line B3587 BO-PRO-3 575/599 Hg-arc lamp, 578 nm line Y3607 YO-PRO-3 612/631 He—Ne laser, 594 nm line T3605 TO-PRO-3 642/661 He—Ne laser, 633 nm line Kr-ion laser, 647 nm line T7596 TO-PRO-5 747/770 Laser diodes 1According to (Haugland, 2002), catalogue numbers are specific to Molecular Probes, Inc. * Wavelengths of excitation (Ex) and emission (Em) maxima, in nm. † Nearest major emission line of some common light sources. -
TABLE 3 Cell-permeant cyanine nucleic acid stains Catalogue #1 Dye Name * Ex/Em † Blue-fluorescent SYTO dyes S11351 SYTO 40 blue-fluorescent nucleic acid stain 419/445 S11352 SYTO 41 blue-fluorescent nucleic acid stain 426/455 S11353 SYTO 42 blue-fluorescent nucleic acid stain 430/460 S11354 SYTO 43 blue-fluorescent nucleic acid stain 437/464 S11355 SYTO 44 blue-fluorescent nucleic acid stain 445/472 S11356 SYTO 45 blue-fluorescent nucleic acid stain 452/484 Green-fluorescent SYTO Dyes S34854 SYTO 9 green-fluorescent nucleic acid stain 483/503 S32704 SYTO 10 green-fluorescent nucleic acid stain 484/505 S34855 SYTO BC green-fluorescent nucleic acid stain 485/500 S7575 SYTO 13 green-fluorescent nucleic acid stain 488/509 S7578 SYTO 16 green-fluorescent nucleic acid stain 488/518 S7559 SYTO 24 green-fluorescent nucleic acid stain 490/515 S7556 SYTO 21 green-fluorescent nucleic acid stain 494/517 S32706 SYTO 27 green-fluorescent nucleic acid stain 495/537 S32705 SYTO 26 green-fluorescent nucleic acid stain 497/534 S7558 SYTO 23 green-fluorescent nucleic acid stain 499/520 S7574 SYTO 12 green-fluorescent nucleic acid stain 500/522 S7573 SYTO 11 green-fluorescent nucleic acid stain 508/527 S7555 SYTO 20 green-fluorescent nucleic acid stain 512/530 S7557 SYTO 22 green-fluorescent nucleic acid stain 515/535 S7577 SYTO 15 green-fluorescent nucleic acid stain 516/546 S7576 SYTO 14 green-fluorescent nucleic acid stain 517/549 S7560 SYTO 25 green-fluorescent nucleic acid stain 521/556 Orange-fluorescent SYTO dyes 532707 SYTO 86 orange-fluorescent nucleic acid stain 528/556 S11362 SYTO 81 orange-fluorescent nucleic acid stain 530/544 S11361 SYTO 80 orange-fluorescent nucleic acid stain 531/545 S11363 SYTO 82 orange-fluorescent nucleic acid stain 541/560 S11364 SYTO 83 orange-fluorescent nucleic acid stain 543/559 S11365 SYTO 84 orange-fluorescent nucleic acid stain 567/582 S11366 SYTO 85 orange-fluorescent nucleic acid stain 567/583 Red-fluorescent SYTO dyes S11346 SYTO 64 red-fluorescent nucleic acid stain 598/620 S11343 SYTO 61 red-fluorescent nucleic acid stain 620/647 S7579 SYTO 17 red-fluorescent nucleic acid stain 621/634 S11341 SYTO 59 red-fluorescent nucleic acid stain 622/645 S11344 SYTO 62 red-fluorescent nucleic acid stain 649/680 S11342 SYTO 60 red-fluorescent nucleic acid stain 652/678 S11345 SYTO 63 red-fluorescent nucleic acid stain 654/675 1According to (Haugland, 2002), catalogue numbers are specific to Molecular Probes, Inc. † Wavelengths of excitation (Ex) and emission (Em) maxima, in nm. -
TABLE 4 Properties of classic nucleic acid stains Fluorescence Catalogue #1 Dye Name Ex/Em * Emission Color Applications † A666 Acridine homodimer 431/498 Green Impermeant AT-selective High-affinity DNA binding A1310 7-AAD (7-amino- 546/647 Red Weakly permeant actinomycin D) GC-selective Flow cytometry Chromosome banding A1324 ACMA 419/483 Blue AT-selective Alternative to quinacrine for chromosome Q banding D1306, D3571, DAPI 358/461 Blue Semi-permeant D21490 AT-selective Cell-cycle studies Chromosome and nuclei counterstain Chromosome banding D1168, D11347, Dihydroethidium 518/605 Red § Permeant D23107 Blue fluorescent until oxidized to ethidium E1305, E3565‡ Ethidium bromide 518/605 Red Impermeant dsDNA intercalator Dead-cell stain Chromosome counterstain Flow cytometry Argon-ion laser excitable E1169 Ethidium homodimer-1 528/617 Red Impermeant (EthD-1) High-affinity DNA labeling Dead-cell stain Argon-ion and green He—Ne laser excitable E3599 Ethidium homodimer-2 535/624 Red Impermeant (EthD-2) Very high-affinity DNA labeling Electrophoresis prestain E1374 Ethidium monoazide 464/625 Red Impermeant (unbound)** Photocrosslinkable H1398, H3569‡, Hoechst 33258 (bis- 352/461 Blue Permeant H21491 benzimide) AT-selective Minor groove-binding dsDNA-selective binding Chromosome and nuclear counterstain H1399, H3570‡, Hoechst 33342 350/461 Blue Permeant H21492 AT-selective Minor groove-binding dsDNA-selective binding Chromosome and nuclear counterstain H21486 Hoechst 34580 392/498 Blue Permeant AT-selective Minor groove-binding dsDNA-selective binding Chromosome and nuclear counterstain H22845 Hydroxystilbamidine 385/emission varies Varies AT-selective with nucleic acid Spectra dependent on secondary structure and sequence RNA/DNA discrimination L7595 LDS 751 543/712 (DNA) Red/infrared Permeant 590/607 (RNA) High Stokes shift Long-wavelength spectra Flow cytometry N21485 Nuclear yellow 355/495 Yellow Impermeant Nuclear counterstain P1304MP, Propidium iodide (PI) 530/625 Red Impermeant P3566‡, P21493 Dead-cell stain Chromosome and nuclear counterstain 1According to (Haugland, 2002), catalogue numbers are specific to Molecular Probes, Inc. * Excitation (Ex) and emission (Em) maxima in nm. † Indication of dyes as “permeant” or “impermeant” are for the most common applications; permeability to cell membranes may vary considerably with the cell type, dye concentrations and other staining conditions. § After oxidation to ethidium. **Prior to photolysis; after photolysis the spectra of the dye/DNA complexes are similar to those of ethidium bromide-DNA complexes. - In some cases, such as DNA and certain polypeptides, a physical characteristic of that molecule can be used, such as the innate autofluorescence in DNA. In such cases, signal intensity can be modulated by the introduction of nanoparticles (see Modulating fluorescence signals with nanoparticles, below).
- Introducing Dye Via Osmolarity/Osmolality Modulation
- The modulation of the concentration of solutes can create an environment that is either hypertonic or hypotonic to cells. By suspending the cells in a hypertonic solution, cells become partially dehydrated. After a short period, they are then transferred to a hypotonic solution. Either, or both solutions can include the dye of interest, but should be present to be available to the cells to enter the cells. Preferably, the dye is present in at least the hypotonic solution. As the cells reach osmotic equilibrium with the solution, water flows into the cell, drawing in the dye across the cell membrane.
- Osmolality can be varied by either adding appropriate salts or other solutes that are compatible with the cells of interest (e.g., KCl, NaCl, MgCl2, MnCl2, CaCl2, sucrose, glucose, etc.), or by diluting the solution with water or buffer. After, collection, cells are transferred to a hypertonic solution for about 0 to about 15 minutes, preferably, about 1 to about10 minutes, more preferably about 3 to about 7 minutes, and most preferably about 5 minutes. The temperature of the solution is about −4° C. to about 39° C., preferably about 0° C. to about 25° C., more preferably 0° C. to about 12° C., and most preferably, about 4° C. The cells are then transferred to a hypotonic solution or the solution in which the cells are in is diluted with buffer to create hypotonic conditions. The temperature of the added solution is bout −4° C. to about 39° C., preferably about 0° C. to about 25″ C, more preferably 0° C. to about 12° C., and most preferably, about 4° C.
- Osmolality conditions vary somewhat by cell type. However, for bovine sperm, hypertonic conditions are created at approximately greater than 250 mOsm, whereas hypotonic conditions are created at approximately less than 250 mOsm (Liu and Foote, 1998). Preferred hypertonic osmalities include 100 mOsm to 249 mOsm; most preferably greater than 150 mOsm, but less than 250 mOsm. Hypotonic osmalities include 251 mOsm to 1537 mOsm; preferably 500 mOsm to 963 mOsm; and most preferably greater than 250 mOsm but less than 732 mOsm. The dye can be any of those listed in Tables 2-4 or other appropriate dye.
- Modulating Fluorescence Signals with Nanoparticles (Quantum Dots and Metallic Nanoparticles)
- Organic and biomolecular fluorophores generally exhibit only moderate Stokes shifts between their excitation and emission spectra, have relatively broad emission spectra, and photobleach when monitored over extended periods of time. A promising alternative to conventional fluorophores is quantum dots (QDs) (Doty et al., 2004).
- In one embodiment, the core of a QD consists of a semiconductor nanocrystal, such as CdSe, surrounded by a passivation shell, such as ZuS. Upon absorption of a photon, an electron-hole pair is generated, the recombination of which in ˜10-20 ns leads to the emission of a less-energetic photon. This energy, and therefore the wavelength, is dependent on the size of the core (smaller->lower wavelength), which can be varied almost at will by controlled-synthesis conditions (Lidke and Amdt-Jovin, 2004). The surface is coated with a polymer that protects the QD from water and allows for chemical coupling to molecules.
- The excitation spectra of QDs are a continuum, rising into the ultraviolet, and the emission spectra are narrow and slightly red-shifted to the band-gap absorption. Thus QDs with different emissions can be excited with a single excitation (Smith and Nie, 2004). The large extinction coefficient and the relatively high quantum yield of QDs, as well as their extraordinary photostability, permit the use of a low sample irradiance and prolonged imaging with a detection sensitivity extending down to the single-QD level.
- QDs are commercially available (e.g., Quantum Dot Corp.; Hayward, Calif. and Evident Technologies; Troy, N.Y.) with a variety of conjugated or reactive surfaces, e.g., amino, carboxyl, streptavidin, protein A, biotin, and immunoglobulins. QDs are non-toxic to most cells. For example, tissue culture cells loaded with QDs survive for weeks without diminished growth or division, and the Q:Ds persisted the entire time (Doty et al., 2004). In live animal studies, mice lived normal lives with QDs for months without obvious deleterious effects (Lidke and Arndt-Jovin, 2004). QDs can be introduced into sexual reproductive cells without harm. For example, Xenopus embryos injected with QDs did not alter the subsequent phenotype; the QDs were viewable throughout development (Smith and Nie, 2004).
- QDs can be targeted to specific areas of the cell, such as the nucleus, by coating them with appropriate molecules, such as DNA-binding molecules (oligonucleotides, DNA-binding proteins, such as histones, transcription factors, polymerases and other molecules of the chromatin, DNA-binding dyes, such as those listed in Tables 2-4, or other small molecules, such as other base intercalators). The particles are suspended with the cells prior to electroporation.
- Similarly, metallic nano-particles can be used to enhance any fluorescent signal, such as those made of gold and silver. They can likewise be tagged with targeting molecules such that they are in close proximity of the stained DNA.
- Dectecting Chromosomal Differences with Nanotransistors and Photo-Activatable Fluorophores
- The ability to incorporate an indicator that has a strongly non-linear response to DNA amount facilitates measuring DNA content, Ideally, this indicator has very little or no fluorescence for the amount of DNA associated with one chromosome, and large amounts of fluorescence for the amount of DNA associated with another chromosome, although in practice approximations to this non-linear response curve are extremely useful. There are several mechanisms that exist for generating such non-linear fluorescence. Photo-activated fluorophores are one such mechanism . Incorporating a photo-activated fluorophore which has a non-linear response to the usual fluorescence emitted by a DNA stain provides a flexible combination of fluorophores whose properties may be tuned to achieve the desired non-linearity (Hogan, 2005). Such photo-activated fluorophores would not necessarily have to be incorporated into the nucleus of the sperm as they may be tuned to respond to fluorescence from the sperm as a whole. By incorporating molecular or nano-transistors into the medium or the sperm, they act as non-linear amplifiers for fluorescence radiated from DNA, either innate autofluorescence or that generated from a stain, Such nano-transistors have countless embodiments because they can be based on biological proteins, or based on quantum dot transistors. There is a significant advantage in that the light that is measured is provided by a strong “pumping” source as opposed to the weak gating source that is usually associated with natural fluorescence of DNA or staining, like Hoescht stains and others listed in Tables 2-4.
- Metallic Nanoparticles and Other Modifiers of Fluorophore Free-Space Spectral Properties
- Nearby conducing metallic particles, colloids or surfaces can modify free-space spectral conditions of fluorophores such that the incident electric field “felt” by the. fluorophore is increased (or decreased), and the rate of radiavity decay can also be modulated (Asian et al., 2004). The radiavity decay rate is that at which a fluorophore emits photons. Because the metallic nanoparticles need to be in close proximity to the fluorescent molecule (approximately about 5 nm), particles can be tagged with fluorescent molecules; or, in the case of polynucleotides (which have a low level of auto fluorescence at 260 nm and 280 nm), tagged with molecules that bind the polynucleotides, such as oligonucleotides, small molecules, or polynucleotide specific binding polypeptides. The particles are suspended with the cells prior to electroporation.
- Flow Cytornetry/Fluoresence-Activated Cell Sorting (FACS)
- Methods of performing flow cytometry are well known (Lidke and Arndt-Jovin, 2004). Flow cytometry (measurement of cells as they flow by a detector) has been available for analysis and sorting a variety of cell types in fluid suspension since the late 1970s. Flow cytometers use focused laser light to illuminate cells as they pass the laser beam, one at a time, in a fine fluid stream. Light scattered by the cells and light emitted by fluorescent dyes attached or loaded in the cells are analyzed by detectors. Cells can be distinguished and selected on the basis of size and shape, as well as by the presence of different molecules inside and on the surface of the cells.
-
FIG. 2 outlines the flow that can be applied to gender-sorting of sperm. The sperm are collected from thedonor 201 and subjected toextension 202 and then cooled slowly to 6° C. Once cooled, the sperm can be subjected to staining DNA by any technique, but preferably the novel techniques of the present invention, using electroporation or osmolality andior nanoparticles of various compositions. The stained cells are introduced into acell sorting device 204 and separated based on gender difference, usually by the sex chromosomes X and Y. The sorted cells are collected, and slowly cooled to 4° C. 205 before being subjected to afinal extension 206. The cells are loaded into cryogenic-compatible straws 207, the cell allowed to settle 208, and then frozen 209. - In the methods of the invention, because of the advantages of staining cells at 4° C. or even cooler, the cells may be cooled to greater than 6° C. as shown in
step 203. Sorting itself 204 can also take place at cooler temperatures, thus preserving cell integrity and cell viability. In many bovine sperm separation protocols, eggs, egg yolks or other sperm-supporting substances are added to the collected sperm to improve viability; however, because the present invention allows for staining and sorting of the cells at cool temperatures9—those in which the cells are metabolically inactive, or nearly so (“metabolically suspended”)—such a step (and the potential of introducing a confounding variable in sorting, being obliged to pre-filter before sorting, and potentially contaminating the sample with microbes) can be eliminated, or the quantity of added egg or other sperm-supporting substances can be reduced to facilitate sorting and other processing. - Eliminating Dead Cells
- After electroporation or osmotic introduction of dyes and/or nanoparticles, a portion of the cell population will usually be nonviable. To increase the quality of the output of the cell populations at the end of processing the cells, dead cells can be removed from the live cells.
- In the case of using fluorescent dyes, such as those that bind DNA listed in Tables 2-4, dead cells and successfully stained, viable cells, both fluoresce. This is because dead cells have compromised cell membranes. To eliminate dead cells from the population, one approach is to add a counter-stain that diminishes the signal. For example, in sperm, membrane-impermeant red food coloring is mixed with the cells. By first dyeing the sperm with an impermeable dye, the Hoechst dye is not able to bind to the DNA since the impermeable dye is already bound. Therefore, the fluorescence of the dead sperm should be either eliminated or a different color, depending on the impermeable DNA dye used. Other classic tests include Trypan blue exclusion, where only non-viable cells allow entry of the dye, diminishing fluorescent signals. In this case, the dye is added after electroporation or osmotic shock, but before sorting.
- The following example is for illustrative purposes only and should not be interpreted as limitations of the claimed invention. There are a variety of alternative teclmiques and procedures available to those of skill in the art which would similarly permit one to successfully perform the intended invention.
- Methods and Materials
- Electroporation unit A sample cell was formed by two parallel glass slides coated with 1,500-2000 angstroms (Å) of indium tin oxide (ITO). The slides were separated by fragments of number zero glass cover slips, yielding a slide separation of 100 millimeters (mm).
- The sample cell was connected to a resistor-capacitator (RC) circuit by alligator clips. A direct current (DC) power supply was used to charge a capacitor. When a switch was thrown, the discharging capacitor generated a time-dependant and spatially uniform electric field across the sample. An oscilloscope was used to monitor the voltage across the sample cell as a function of time.
- The RC circuit formed by the sample cell and capacitor allowed for a well-controlled electric field to be generated. The resistance (R) of the circuit was left floating—that is, determined by the geometry and content of the sample cell. Typical R values ranged from 2-10,000 watts (W) depending primarily on the electrical conductivity of the buffer. The capacitance was varied from 0.1 millifarads (mF) to 1000 mF.
- Cells Bovine sperm that had been previously frozen were thawed for 60 seconds in a 96° F. water bath. Sperm were then centrifuged at 2,000 rotations per minute (rpm) for two minutes and the supernatant decanted. Sperm were then re-suspended with 0.35 M sucrose to partially dehydrate the sperm. The sperm solution was then incubated at 96 ° F. for 15 minutes and then transferred to the sample cell of the electroporation unit.
- Electroporation A voltage was applied to the capacitor circuit, and then the power supply was disconnected. A switch was then thrown and the capacitor discharged across the sample cell. These steps were carried out within 15 seconds of transferring the sperm to the sample cell to retain a random orientation of sperm with respect to the electric field. Electroporation was carried out on sperm in isotonic (0.25 M sucrose) and hypertonic (0.35 M sucrose) solutions. In each case, 10 V was applied to the capacitor and a time constant of 0.26 milliseconds (ms) measured.
- A solution of 0.1 M sucrose and the DNA-specific dye, propidium iodide, was then injected into the sample cell, Fluorescence microscopy is used to image the sperm,
- Results
- Since propidium iodide dye does not breach the cell membrane barrier, only cells that have had their membranes compromised, such as by electroporation, allow entry of the dye, which then binds to any DNA in the cell (the nucleus and mitochondria), and, when excited with the appropriate wavelength of light, fluoresces. To distinguish fluorescent dead cells from fluorescent live cells, sperm motility was assessed.
- In each case (isotonic and hypertonic/hypotonic solution), motile and fluorescent sperm were observed. However, the number of these sperm was enhanced by approximately five-ten fold in the hypertonic/hypotonic solution. Control samples unexposed to electric fields did not yield motile and fluorescent sperm.
- Motility was examined in the hypertonic/hypotonic solution and compared to a control sample unexposed to an electric field. The electroporated sample yielded a loss of 70% of motile sperm compared to the control. In addition, the electroporated sample showed a 68% increase in the number of damaged and non-motile sperm. All of the observed motile sperm in the hypertonicihypotonic solution exposed to the electric field displayed fluorescence.
- Larger field strengths, multiple pulses, alternating current (AC) fields, buffers with larger osmotic pressures, and longer time constants led to complete loss of sperm motility. Weaker field strengths and shorter time constants did not yield fluorescent motile sperm.
- A temporary spatially uniform electric field allows non-permeant membrane dyes to cross bovine sperm cell membranes. A 70% loss in motility was associated with this process—but manipulating procedure parameters can reduce the death toll. This technique also allows for the introduction of nanoparticles into sperm and other membrane bound-cells.
-
- Asian, K., J. R. Lakowicz, H. Szrnacinski, and C. D. Geddes. 2004. Metal-enhanced fluorescence solution-based sensing platform. J Fluoresc. 14:677-9.
- Ballou, B., B. C. Lagerholm, L. A. Ernst, M. P. Bruchez, and A. S. Waggoner. 2004. Noninvasive imaging of quantum dots in mice. Bioconjug Chem. 15:79-86.
- Chamberlain, C., and K. M. Hahn. 2000. Watching proteins in the wild: fluorescence methods to study protein dynamics in living cells. Traffic. 1:755-62.
- Doty, R. C., D. G. Fernig, and R. Levy. 2004. Nanoscale science: a big step towards the Holy Grail of single molecule biochemistry and molecular biology. Cell Mal Life Sci. 61:1843-9.
- Dubertret, B., P. Skourides, D. J. Norris, ti. Noireaux, A. H. Brivanlou, and A. Libchaber. 2002. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science. 298:1759-62.
- Gehl, J. 2003. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Stand. 177:437-47.
- Haugland, R. P. 2002. Handbook of fluroescent probes and research products. Molecular Probes, Inc., Eugene, Oreg.
- Hogan, H. 2005. Fluorescence at the flip of a molecular s.witch. Biophotonics Intern'I. January: 34-38.
- Jaiswal, J. K., H. Mattoussi, J. M. Mauro, and S. M. Simon. 2003. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol. 21:47-51.
- Johnson, L. A. 1992. Method to preselect the sex of offspring, U.S. Pat. No. 5,135,759.
- Kim, S., Y. T. Lim, E. G. Soltesz, A. M. De Grand, J. Lee, A. Nakayama, J. A. Parker, T. Mihaljevic, R. G. Laurence, D. M. Dor, L. H. Cohn, M. G. Bawendi, and J. V. Frangioni. 2004, Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol. 22:93-7.
- Lidke, D. S., and D. J. Arndt-Jovin. 2004. Imaging takes a quantum leap. Physiology (Bethesda). 19:322-5.
- Liu, Z., and R. H. Foote. 1998. Bull sperm motility and membrane integrity in media varying in osmolality. J Dairy Sci. 81:1868-73.
- Orfao, A., and A. Ruiz-Arguelles. 1996. General concepts about cell sorting techniques. Clin Biochem. 29:5-9.
- Potter, H., L. Weir, and P. Leder. 1984. Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Arad Sci USA. 81:7161-5.
- Rieth, A., F. Pothier, and M. A. Sirard. 2000. Electroporation of bovine spermatozoa to carry DNA containing highly repetitive sequences into oocytes and detection of homologous recombination events. Mol Reprod Dev. 57:338-45.
- Smith, A. M., and S. Nie. 2004. Chemical analysis and cellular imaging with quantum dots. Analyst. 129:672-7.
Claims (25)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/476,509 US20170204370A1 (en) | 2005-02-01 | 2017-03-31 | Methods for staining cells for identification and sorting |
US16/561,146 US20190390164A1 (en) | 2005-02-01 | 2019-09-05 | Methods for staining cells for identification and sorting |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/048,101 US20060172315A1 (en) | 2005-02-01 | 2005-02-01 | Methods for staining cells for identification and sorting |
US12/379,063 US9453849B2 (en) | 2005-02-01 | 2009-02-11 | Methods for staining cells for identification and sorting |
US15/276,747 US20170016879A1 (en) | 2005-02-01 | 2016-09-26 | Methods for staining cells for identification and storing |
US15/476,509 US20170204370A1 (en) | 2005-02-01 | 2017-03-31 | Methods for staining cells for identification and sorting |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/276,747 Continuation US20170016879A1 (en) | 2005-02-01 | 2016-09-26 | Methods for staining cells for identification and storing |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/561,146 Continuation US20190390164A1 (en) | 2005-02-01 | 2019-09-05 | Methods for staining cells for identification and sorting |
Publications (1)
Publication Number | Publication Date |
---|---|
US20170204370A1 true US20170204370A1 (en) | 2017-07-20 |
Family
ID=36757022
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/048,101 Abandoned US20060172315A1 (en) | 2005-02-01 | 2005-02-01 | Methods for staining cells for identification and sorting |
US12/379,063 Active 2027-01-05 US9453849B2 (en) | 2005-02-01 | 2009-02-11 | Methods for staining cells for identification and sorting |
US15/276,747 Abandoned US20170016879A1 (en) | 2005-02-01 | 2016-09-26 | Methods for staining cells for identification and storing |
US15/476,509 Abandoned US20170204370A1 (en) | 2005-02-01 | 2017-03-31 | Methods for staining cells for identification and sorting |
US16/561,146 Abandoned US20190390164A1 (en) | 2005-02-01 | 2019-09-05 | Methods for staining cells for identification and sorting |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/048,101 Abandoned US20060172315A1 (en) | 2005-02-01 | 2005-02-01 | Methods for staining cells for identification and sorting |
US12/379,063 Active 2027-01-05 US9453849B2 (en) | 2005-02-01 | 2009-02-11 | Methods for staining cells for identification and sorting |
US15/276,747 Abandoned US20170016879A1 (en) | 2005-02-01 | 2016-09-26 | Methods for staining cells for identification and storing |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/561,146 Abandoned US20190390164A1 (en) | 2005-02-01 | 2019-09-05 | Methods for staining cells for identification and sorting |
Country Status (1)
Country | Link |
---|---|
US (5) | US20060172315A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107505303A (en) * | 2017-10-09 | 2017-12-22 | 华中农业大学 | A kind of seedling stage Rapid identification hops plant male and female method for distinguishing |
CN110680556A (en) * | 2019-11-12 | 2020-01-14 | 鼠来宝(武汉)生物科技有限公司 | Mouse in-vitro fertilization reagent, preparation method thereof and in-vitro fertilization method |
US10961577B2 (en) | 2017-09-01 | 2021-03-30 | Genus Plc | Methods and systems for assessing and/or quantifying sperm cell subpopulations bearing a specific genetic signature |
RU2787056C1 (en) * | 2022-05-06 | 2022-12-28 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский государственный аграрный университет - МСХА имени К.А. Тимирязева" (ФГБОУ ВО РГАУ - МСХА имени К.А. Тимирязева) | Method for predicting the total bacterial contamination of freshly obtained stallion sperm |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11243494B2 (en) | 2002-07-31 | 2022-02-08 | Abs Global, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
AU2008338530A1 (en) * | 2007-12-14 | 2009-06-25 | Minitube Of America, Inc. | Gender-specific separation of sperm cells and embryos |
US20110201047A1 (en) * | 2008-10-14 | 2011-08-18 | Cornell University | novel sorting technology that allows for highly efficient selection of sperm without chromatin damage |
US8504528B2 (en) * | 2009-11-09 | 2013-08-06 | Ca, Inc. | Duplicate backup data identification and consolidation |
US10908066B2 (en) | 2010-11-16 | 2021-02-02 | 1087 Systems, Inc. | Use of vibrational spectroscopy for microfluidic liquid measurement |
RU2532839C2 (en) * | 2012-11-21 | 2014-11-10 | Общество с ограниченной ответственностью Научно-технический центр "БиоКлиникум" (ООО НТЦ "Биоклиникум) | Method of estimating cell viability in microbioreactor by means of optical light guide |
US8961904B2 (en) | 2013-07-16 | 2015-02-24 | Premium Genetics (Uk) Ltd. | Microfluidic chip |
US11796449B2 (en) | 2013-10-30 | 2023-10-24 | Abs Global, Inc. | Microfluidic system and method with focused energy apparatus |
EP4137798A1 (en) | 2015-02-19 | 2023-02-22 | 1087 Systems, Inc. | Scanning infrared measurement system |
CN105132364B (en) * | 2015-09-08 | 2018-12-14 | 徐小杨 | sperm selection method and carrier |
US11415493B2 (en) * | 2016-03-17 | 2022-08-16 | Perkinelmer Health Sciences B.V. | Detection of cells in a liquid sample |
CN106932330A (en) * | 2017-03-07 | 2017-07-07 | 浙江星博生物科技股份有限公司 | A kind of sperm DFI detection methods based on flow cytometry |
WO2019226790A1 (en) | 2018-05-23 | 2019-11-28 | Abs Global, Inc. | Systems and methods for particle focusing in microchannels |
CN117413819A (en) | 2019-04-18 | 2024-01-19 | 艾步思国际有限责任公司 | System and process for continuous addition of cryoprotectant |
US11628439B2 (en) | 2020-01-13 | 2023-04-18 | Abs Global, Inc. | Single-sheath microfluidic chip |
EP4056710A1 (en) * | 2021-03-12 | 2022-09-14 | Universität für Bodenkultur Wien | Method for the detection of particles |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6474451A (en) | 1987-09-16 | 1989-03-20 | Showa Denko Kk | Sell selection device |
EP0471758B1 (en) * | 1989-05-10 | 1996-09-11 | THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE | Method to preselect the sex of offspring |
JPH07286953A (en) | 1994-04-19 | 1995-10-31 | Toa Medical Electronics Co Ltd | Imaging flow sight meter |
US6368855B1 (en) * | 1996-06-11 | 2002-04-09 | Antigen Express, Inc. | MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression |
US6416959B1 (en) * | 1997-02-27 | 2002-07-09 | Kenneth Giuliano | System for cell-based screening |
US6071689A (en) * | 1997-12-31 | 2000-06-06 | Xy, Inc. | System for improving yield of sexed embryos in mammals |
FR2801671B1 (en) | 1999-11-29 | 2001-12-21 | Commissariat Energie Atomique | DEVICE FOR MEASURING, BY DIFFRACTION, SIZES OF SUBSTANTIALLY SPHERICAL PARTICLES, ESPECIALLY OPAQUE DROPS |
US7250292B2 (en) * | 2000-01-26 | 2007-07-31 | 21St Century Medicine | Hypertonic reduction of chilling injury |
AU2001284968B2 (en) * | 2000-08-16 | 2006-12-21 | Duke University | Decellularized tissue engineered constructs and tissues |
US20050064383A1 (en) * | 2000-11-22 | 2005-03-24 | Bashkin James K. | Methods and apparatus for producing gender enriched sperm |
WO2002045125A1 (en) * | 2000-12-01 | 2002-06-06 | Yeda Research And Development Co. Ltd. | Device and method for the examination of samples in a non-vacuum environment using a scanning electron microscope |
JP2003106980A (en) | 2001-10-01 | 2003-04-09 | Nec Corp | Measuring device and measuring method for minute particle group |
US8889414B2 (en) * | 2001-10-31 | 2014-11-18 | The Regents Of The University Of California | Semiconductor nanocrystal-based phagokinetic tracking |
JP2007518107A (en) * | 2004-01-13 | 2007-07-05 | ユー.エス. ジェノミクス, インコーポレイテッド | Detection and quantification of analytes in solution using polymers |
-
2005
- 2005-02-01 US US11/048,101 patent/US20060172315A1/en not_active Abandoned
-
2009
- 2009-02-11 US US12/379,063 patent/US9453849B2/en active Active
-
2016
- 2016-09-26 US US15/276,747 patent/US20170016879A1/en not_active Abandoned
-
2017
- 2017-03-31 US US15/476,509 patent/US20170204370A1/en not_active Abandoned
-
2019
- 2019-09-05 US US16/561,146 patent/US20190390164A1/en not_active Abandoned
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10961577B2 (en) | 2017-09-01 | 2021-03-30 | Genus Plc | Methods and systems for assessing and/or quantifying sperm cell subpopulations bearing a specific genetic signature |
CN107505303A (en) * | 2017-10-09 | 2017-12-22 | 华中农业大学 | A kind of seedling stage Rapid identification hops plant male and female method for distinguishing |
CN110680556A (en) * | 2019-11-12 | 2020-01-14 | 鼠来宝(武汉)生物科技有限公司 | Mouse in-vitro fertilization reagent, preparation method thereof and in-vitro fertilization method |
RU2787056C1 (en) * | 2022-05-06 | 2022-12-28 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский государственный аграрный университет - МСХА имени К.А. Тимирязева" (ФГБОУ ВО РГАУ - МСХА имени К.А. Тимирязева) | Method for predicting the total bacterial contamination of freshly obtained stallion sperm |
Also Published As
Publication number | Publication date |
---|---|
US20190390164A1 (en) | 2019-12-26 |
US20060172315A1 (en) | 2006-08-03 |
US9453849B2 (en) | 2016-09-27 |
US20090226880A1 (en) | 2009-09-10 |
US20170016879A1 (en) | 2017-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190390164A1 (en) | Methods for staining cells for identification and sorting | |
Hoshino et al. | Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body | |
Kuo et al. | Optical painting and fluorescence activated sorting of single adherent cells labelled with photoswitchable Pdots | |
Progatzky et al. | From seeing to believing: labelling strategies for in vivo cell-tracking experiments | |
Shapiro | Microbial analysis at the single-cell level: tasks and techniques | |
Weigert et al. | Intravital microscopy: a novel tool to study cell biology in living animals | |
Hadjantonakis et al. | Dynamic in vivo imaging and cell tracking using a histone fluorescent protein fusion in mice | |
JP6228205B2 (en) | Methods and compositions for preparing biological specimens for microanalysis | |
EP2312943B1 (en) | Method for assessing viable cells and the use of n-(7-dimethylamino-4-methyl-3-coumarinyl)-maleimide (dacm) or n-(9-acridinyl)maleimide (nam) for assessment of apoptosis. | |
US10656073B2 (en) | Optical painting and fluorescence-activated sorting of adherent cells | |
Bongaerts et al. | Green fluorescent protein as a marker for conditional gene expression in bacterial cells | |
WO2002041906A2 (en) | Methods and apparatus for producing gender enriched sperm | |
JP2006525019A (en) | Sperm staining method | |
JP2012522518A (en) | Method and apparatus for sorting cells and bioparticles | |
SE506700C2 (en) | Probe and Methods for Analysis of Nucleic Acid | |
Dmitriev et al. | Luminescence lifetime imaging of three-dimensional biological objects | |
Thal et al. | Ligand-conjugated quantum dots for fast sub-diffraction protein tracking in acute brain slices | |
Okkelman et al. | Multi-parametric imaging of hypoxia and cell cycle in intestinal organoid culture | |
Peiris et al. | Alternative flow cytometry strategies to analyze stem cells and cell death in planarians | |
Courty et al. | Tracking individual proteins in living cells using single quantum dot imaging | |
Tomlinson et al. | Peptide-conjugated quantum dots: imaging the angiotensin type 1 receptor in living cells | |
WO2017205531A1 (en) | Methods for visualization and quantification of fiber-like structures | |
Morgan et al. | Imaging techniques in retinal research | |
Mobbs et al. | Techniques for dye injection and cell labelling | |
Loukanov | Two‐photon microscopy assessment of the overall energy metabolism alteration of amoeba in hypertonic environment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
AS | Assignment |
Owner name: PREMIUM GENETICS (UK) LIMITED, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ARRYX, INC.;REEL/FRAME:049506/0633 Effective date: 20130328 Owner name: ARRYX, INC., ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MUETH, DANIEL;PLEWA, JOSEPH;KNUTSON, CHRISTOPHER;AND OTHERS;SIGNING DATES FROM 20070309 TO 20070606;REEL/FRAME:049506/0553 |
|
AS | Assignment |
Owner name: ABS GLOBAL, INC., WISCONSIN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PREMIUM GENETICS (UK) LIMITED;REEL/FRAME:050201/0345 Effective date: 20190430 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |